Mechanisms of Nicotine Addiction
Open accessAbstract
Tobacco smoking results in more than five million deaths each year and accounts for ∼90% of all deaths from lung cancer.3 Nicotine, the major reinforcing component of tobacco smoke, acts in the brain through the neuronal nicotinic acetylcholine receptors (nAChRs).The nAChRs are allosterically regulated, ligand-gated ion channels consisting of five membrane-spanning subunits.Twelve mammalian α subunits (α2-α10) and three β subunits (β2-β4) have been cloned.The predominant nAChR subtypes in mammalian brain are those containing α4 and β2 subunits (denoted as α4β2 Ã nAChRs).The α4β2 Ã nAChRs mediate many behaviors related to nicotine addiction and are the primary targets for currently approved smoking cessation agents.Considering the large number of nAChR subunits in the brain, it is likely that nAChRs containing subunits in addition to α4 and β2 also play a role in tobacco smoking.Indeed, genetic variation in the CHRNA5-CHRNA3-CHRNB4 gene cluster, encoding the α5, α3, and β4 nAChR subunits, respectively, has been shown to increase vulnerability to tobacco dependence and smoking-associated diseases including lung cancer.Moreover, mice, in which expression of α5 or β4 subunits has been genetically modified, have profoundly altered patterns of nicotine consumption.In addition to the reinforcing properties of nicotine, the effects of nicotine on appetite, attention, and mood are also thought to contribute to establishment and maintenance of the tobacco smoking habit.Here, we review recent insights into the behavioral actions of nicotine, and the nAChR subtypes involved, which likely contribute to the development of tobacco dependence in smokers.
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes evidence on the nicotinic acetylcholine receptor (nAChR) subtypes and neural circuits that mediate nicotine's reinforcing, aversive, and withdrawal-related actions, arguing that α4β2-containing receptors in the mesolimbic dopamine system drive reinforcement while α5/α3/β4-containing receptors in the habenula-interpeduncular pathway limit intake. It also covers nAChR contributions to nicotine's effects on mood, attention, and appetite, and suggests these subtypes as targets for smoking-cessation therapeutics.
Key findings
- α4β2* nAChRs are the predominant brain subtypes and mediate nicotine reinforcement: β2 knockout abolishes nicotine-mediated DA release, locomotor activation, self-administration, and place preference, while α4 knockout abolishes i.c.v. nicotine self-administration; hypersensitive α4 or α6 knockin shifts the dose-response for DA neuron firing leftward and produces place preference at very low nicotine doses.
- α4/α6/β2* nAChRs on VTA dopamine neurons are identified as essential for nicotine reinforcement; α6 knockout mice do not acquire nicotine self-administration, and α6/β2-selective conotoxins infused into the VTA disrupt self-administration and reduce progressive-ratio motivation.
- The CHRNA5 SNP rs16969968 (minor allele frequency = 0.42 in those of European descent) increases tobacco dependence risk by ∼30% with one copy and more than doubles it with two; the same 15q25 variation is a major risk factor for lung cancer and COPD.
- α5* nAChRs in the MHb-IPN pathway limit nicotine intake: α5 knockout mice self-administer far more nicotine at higher unit doses, and reexpression of α5 in the MHb-IPN abolishes this increase; β4 overexpression reduces consumption, and α5/α2 knockouts show no somatic withdrawal signs after mecamylamine precipitation.
- Nicotine's non-reinforcing effects involve distinct subtypes: β4* nAChRs on hypothalamic POMC neurons are necessary for nicotine's appetite suppression (smokers weigh ∼5 kg less than nonsmokers on average), β2* nAChRs in prelimbic mPFC are important for visual attention, and β2* and α7* nAChRs in hippocampus and basolateral amygdala regulate anxiety- and depression-like behaviors.
Methods
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
91 of 193 cited sources checked · 43 supported · 0 flagged · accuracy not yet measured
- Premisecitation
The α6 subunit appears to be selectively expressed in DA neurons.
“The α6 subunit appears to be selectively expressed in DA neurons (Le Novere et al. 1996;Drenan et al. 2008b)”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Le Novere et al. 1996 source
The title in our indexed copy says α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. The available passages do not specifically identify DA neurons or establish selective expression in them; they support the broader localization claim only. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites Drenan et al. 2008b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Knockout of the α4 subunit abolishes intracerebroventricular self-administration of nicotine.
“Similarly, knockout of the α4 subunit abolishes intracerebroventricular (i.c.v.) selfadministration of nicotine, consistent with evidence that α4/β2 Ã nAChRs are required for depolarization of DA neurons in the VTA (Exley et al. 2011;McGranahan et al. 2011).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Exley et al. 2011 source
The Results report that α4-knockout mice did not sustain nicotine self-administration beyond session 3, supporting the loss of sustained self-administration. But the experiment delivered nicotine intracranially into the VTA, not intracerebroventricularly, and the mice showed initial approach behavior rather than an immediate abolition of the response. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites McGranahan et al. 2011 source
The Results section, “α4*-nAChRs on Dopaminergic Neurons Mediate Nicotine Reward” (page unavailable), reports that α4-knockout mice did not develop nicotine conditioned place preference. The Methods section, “Conditioned Place Preference” (page unavailable), describes intraperitoneal nicotine injections, not intracerebroventricular self-administration. The paper supports a loss of nicotine reward in this test, but not the specified self-administration claim. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Nicotine can desensitize β2* nAChRs on GABAergic inputs to DA neurons, shifting from mixed excitation and inhibition to more unmixed stimulation of nAChRs on presynaptic glutamatergic terminals.
“In addition, nicotine can desensitize β2 Ã nAChRs on GABAergic inputs to DA neurons, resulting in a shift from mixed excitation and inhibition of DA neurons by nicotine, to a more unmixed stimulation of nAChRs on presynaptic glutamatergic terminals (Mansvelder et al. 2002;Wooltorton et al. 2003).”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
The MHb projects almost exclusively to the IPN via the fasciculus retroflexus.
“Unlike LHb, the MHb projects almost exclusively to the interpeduncular nucleus (IPN) via the fasciculus retroflexus (Fr) (Lecourtier and Kelly 2007;Hikosaka 2010).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Lecourtier and Kelly 2007 source
- cites Hikosaka 2010 source
The Abstract (page unavailable) says that MHb neurons project to the IPN and identifies the fasciculus retroflexus as the habenula’s output tract. It contrasts this with LHb projections to other midbrain areas, but does not establish that MHb projections to the IPN are almost exclusive. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Mice lacking the α6 subunit do not acquire nicotine self-administration.
“Mice lacking the α6 subunit do not acquire nicotine self-administration (Pons et al. 2008).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Pons et al. 2008 source
- Premisecitation
Chemical inactivation of the MHb or IPN with lidocaine, or disruption of NMDA receptor-mediated glutamatergic transmission with LY2358959, increased nicotine self-administration in rats similarly to α5 knockout.
“Chemical inactivation of the MHb or the IPN using the local anesthetic lidocaine, or disruption of N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic transmission in these sites using the competitive antagonist LY2358959, increased nicotine self-administration behavior in rats in a manner similar to the α5 nAChR subunit knockout mice (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
In “Habenular-IPN activity limits nicotine intake,” lidocaine inactivation of the IPN or MHb and NMDA-receptor antagonism at those sites increased nicotine self-administration in rats, consistent with the knockout findings reported elsewhere in the paper. The source names the antagonist LY235959, not LY2358959; it also reports the MHb effects only at a higher nicotine dose. Page numbers were not provided in the supplied passages. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
α5 knockout mice consumed more nicotine only when higher unit doses were available.
“Interestingly, the knockout mice consumed more nicotine only when higher unit doses of the drug were available (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
In “α5* nAChRs control nicotine intake” (page unavailable), the paper reports that knockout mice consumed greater amounts as the unit dose increased and responded more vigorously especially at higher doses. It does not establish the claim’s stricter “only” condition: the passage says “especially,” not that increased consumption occurred exclusively at higher doses. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Mice with a null mutation in the α5 subunit intravenously self-administered far more nicotine than wild-type littermates.
“Consistent with an important role for α5 Ã nAChRs in regulating nicotine intake, it was recently shown that mice with null mutation in this subunit intravenously self-administered far more nicotine than their wild-type littermates (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
- Premisecitation
RNA interference-mediated knockdown of α5 nAChR subunits in the MHb-IPN pathway in rats increased nicotine intake at higher unit doses, similar to α5 knockout mice.
“Conversely, RNA interference-mediated knockdown of α5 nAChR subunits in the MHb-IPN pathway in rats resulted in increased nicotine intake at higher unit doses of the drug, very similar to the same behavioral profile detected in the knockout mice (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
- Premisecitation
Chronic nicotine exposure increases action potential firing and nicotine sensitivity of MHb and IPN neurons.
“Interestingly, chronic nicotine exposure increases action potential firing and nicotine sensitivity of MHb and IPN neurons (Arvin et al. 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Arvin et al. 2019 source
The Discussion (page not provided) reports enhanced action-potential firing in MHb neurons and increased nicotinic receptor function in MHb and IPN neurons. The section on nicotine sensitivity in rostral IPN neurons reports stronger nicotine-evoked depolarization, but does not report increased action-potential firing in IPN neurons; most recorded IPN neurons were not spontaneously firing. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Knockdown of α5 nAChR subunits in the MHb-IPN pathway in rats decreased sensitivity to the aversive actions of higher nicotine doses compared with controls, as measured by ICSS reward thresholds.
“Finally, knockdown of α5 nAChR subunits in the MHb-IPN pathway in rats decreased their sensitivity to the reward-inhibiting (i.e., aversive) actions of higher nicotine doses compared with control rats, as measured by nicotine-induced elevations of intracranial self-stimulation (ICSS) reward thresholds (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
- Premisecitation
The MHb-IPN pathway of α5 knockout mice was far less sensitive to nicotine-induced activation than that of wild-type mice, as measured by Fos immunoreactivity.
“By using Fos immunoreactivity as a measure of neuronal activation, it was shown that the MHb-IPN pathway of the knockout mice was far less sensitive to nicotine-induced activation than wild-type mice (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
- Premisecitation
Virus-mediated reexpression of the α5 nAChR subunit in the MHb-IPN pathway of knockout mice abolished the increased nicotine intake seen at higher doses.
“Virus-mediated reexpression of the α5 nAChR subunit in the MHb-IPN pathway of knockout mice abolished the increased nicotine intake seen at higher doses of nicotine (Fowler et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fowler et al. 2011 source
- Premisecitation
Allelic variation in the α5/α3/β4 nAChR subunit gene cluster at chromosome 15q25 significantly increases risk of tobacco addiction.
“It has been shown that allelic variation in the α5/α3/β4 nAChR subunit gene cluster located in chromosome region 15q25 significantly increases risk of tobacco addiction (Saccone et al. 2007;Berrettini et al. 2008;Lips et al. 2010).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Saccone et al. 2007 source
- cites Berrettini et al. 2008 source
- cites Lips et al. 2010 source
The Results and Discussion report that a variant in the 15q25 receptor-gene cluster is associated with smoking more cigarettes per day and with heavy smoking. They do not establish the claimed significant increase in risk of tobacco addiction: the paper distinguishes smoking quantity from nicotine dependence, and the Results find no association with smoking initiation or cessation. Page numbers are not available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
GLP-1-immunoreactive fibers can be detected in the IPN of mice.
“Consistent with this possibility, GLP-1-immunoreactive fibers can be detected in the IPN of mice (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
- Premisecitation
RNA interference-mediated knockdown of GLP-1 receptor transcripts in MHb neurons increased nicotine intake in rats, particularly when higher unit doses were available.
“Consistent with this hypothesis, RNA interference-mediated knockdown of GLP-1 receptor transcripts in MHb neurons increased nicotine intake in rats, particularly when higher unit doses were available (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
- Premisecitation
Infusion of the GLP-1 receptor antagonist exendin-(9-39)-amide into the IPN increased nicotine intake in rats.
“Infusion of the GLP-1 receptor antagonist exendin-(9-39)-amide (Ex-9) into the IPN similarly increased nicotine intake in rats (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
- Premisecitation
Nicotine self-administration behavior is markedly enhanced by TCF7L2 deficiency in Tcf7l2 mutant rats.
“Using a line of Tcf7l2 mutant (Tcf7l2 mut ) rats in which the DNA-binding do-main of TCF7L2 was deleted using zinc finger nucleases it was shown that nicotine self-administration behavior is markedly enhanced by TCF7L2 deficiency (Duncan et al. 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Duncan et al. 2019 source
The “Habenular Tcf7l2 regulates nicotine intake” section reports that Tcf7l2 mutant rats responded far more vigorously than wild-type rats for intravenous nicotine, supporting the behavioral claim. However, the citing sentence says the DNA-binding domain was deleted; the source says zinc finger nucleases deleted the β-catenin-binding domain. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
TCF7L2 is highly enriched in MHb neurons.
“Notably, TCF7L2 is highly enriched in MHb neurons (Duncan et al. 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Duncan et al. 2019 source
- Premisecitation
When channelrhodopsin-2 is expressed in GLP-1 neurons in the NTS, optical stimulation of GLP-1 terminals increases the frequency but not the amplitude of oEPSCs in IPN neurons.
“Further-more, when channelrhodopsin-2 is expressed in GLP-1 neurons in the NTS, optical stimulation of GLP-1 terminals increased the frequency but not the amplitude of postsynaptic currents (oEPSCs) in IPN neurons (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
The Results section (‘GLP-1 stimulates habenular inputs to the interpeduncular nucleus’) reports that stimulation of ChR2-expressing GLP-1 terminals increased EPSC frequency but not amplitude in IPN neurons. The claim omits a decisive condition: this occurred with high-frequency (20 Hz) stimulation, not low-frequency (1 Hz) stimulation. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
α2 subunits are highly enriched in the IPN, similar to α5 subunits.
“Similar to α5 subunits, α2 subunits are highly enriched in the IPN (Grady et al. 2009).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Grady et al. 2009 source
The Results (Subunit composition of nAChRs in rat interpeduncular nucleus; page unavailable) report α2 and α5 in the IPN, but classify both as present at moderate levels, not high levels. The Discussion (Native subtypes in the habenulo-interpeduncular system; page unavailable) says α2β2* receptors are restricted to the IPN relative to the habenula. That supports IPN localization, but not the claim that α2 and α5 are both highly enriched there. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
The amplitude of nicotine-evoked nAChR currents in MHb slices was similar in wild-type and TCF7L2-deficient rats.
“Using whole-cell recordings to assess pharmacologically isolated nAChR currents in MHb slices, it was shown that the amplitude of nicotine-evoked nAChR currents were similar in wild-type and TCF7L2-deficent rats (Duncan et al. 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Duncan et al. 2019 source
- Premisecitation
nAChRs in the MHb of TCF7L2-deficient rats failed to recover from nicotine-induced desensitization, unlike nAChRs in wild-type rats.
“However, unlike nAChRs in the MHb of wild-type rats, nAChRs failed to recover from nicotine-induced desensitization in TCF7L2deficent rats (Duncan et al. 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Duncan et al. 2019 source
- Premisecitation
Chemogenetic activation of GLP-1 neurons in the NTS decreased nicotine intake in mice.
“Chemogenetic activation of GLP-1 neurons in the NTS similarly decreased nicotine intake in mice (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
- Premisecitation
Systemic delivery of the GLP-1 receptor agonist exendin-4 or the DPP-4 inhibitor sitagliptin decreased responding for nicotine infusions but not food rewards in mice.
“Systemic delivery of the GLP-1 receptor agonist exendin-4 (Ex4), or the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin (to inhibit GLP-1 breakdown) decreased responding for nicotine infusions but not food rewards in mice (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
The Results section (“GLP-1 regulates nicotine intake”; page not available) reports that Ex-4 decreased nicotine intake in mice without altering food-reward responding, and that sitagliptin also decreased nicotine self-administration. It does not specifically report a food-reward test for sitagliptin, so the claim that neither drug affected food responding goes beyond the drug-specific results, despite the Discussion’s broader statement that food responding was unaffected by GLP-1 manipulations. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Inhibition of TCF7L2 activity in the MHb, by CRISPR-Cas9 cleavage in mice or siRNAs in rats, dramatically increases nicotine intake.
“Inhibition of TCF7L2 activity in the MHb, accomplished in mice by CRISPR-Cas9 cleavage of Tcf7l2 DNA or in rats by local delivery of short interfering RNAs to knock down Tcf7l2 transcripts, dramatically increases nicotine intake (Duncan et al. 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Duncan et al. 2019 source
- Premisecitation
Infusion of Ex-4 into the IPN decreased nicotine intake in rats.
“Conversely, infusion of Ex-4 into the IPN decreased nicotine intake in rats (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
- Premisecitation
Nicotinic partial agonists are effective in human smokers.
“and in human smokers (Philip et al. 2009)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Philip et al. 2009 source
The Introduction identifies varenicline as a nicotinic partial agonist, and the Abstract Results report improved depressive symptoms and reduced smoking among depressed smokers who received it. But this eight-week, open-label study of one drug does not establish that nicotinic partial agonists as a class are effective in human smokers generally; the Discussion says the findings suggest varenicline may have antidepressant properties in smokers with treatment-resistant depression. No page numbers are available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Infusion of mecamylamine into the BLA decreases stress-induced immobility.
“Infusion of the broad nAChR antagonist mecamylamine into the BLA decreases stress-induced immobility”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Mineur et al. 2016 source
- Premisecitation
Female but not male mice lacking the α5 nAChR subunit show reduced anxiety-like behavior.
“female, but not male, knockout mice lacking the α5 subunit showed reduced anxiety-like behavior”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Gangitano et al. 2009 source
- Premisecitation
Chronic nicotine administration increases anxiety-like behavior in female mice but not in male mice.
“chronic administration of nicotine increased anxiety-like behavior in female, but not male, mice (Caldarone et al. 2008)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Caldarone et al. 2008 source
- Interpretationreasoning
Elevated ACh levels observed in human subjects who are actively depressed contribute to the disorder.
“supports the idea that the elevated ACh levels observed in human subjects who are actively depressed contributes to the disorder (Saricicek et al. 2012;Hannestad et al. 2013).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Saricicek et al. 2012 source
The Discussion reports lower β2*-nAChR availability in actively depressed patients and suggests that increased extracellular ACh, rather than fewer receptors, likely explains it. ACh levels were inferred rather than directly observed, and this study does not establish that the inferred increase causes or contributes to depression. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Hannestad et al. 2013 source
The Results report lower receptor availability in actively depressed subjects, not a direct measurement of elevated ACh. The Discussion suggests that higher extracellular ACh may explain the finding and could be associated with depression, but it does not establish that elevated ACh was observed or that it contributes causally to the disorder. No page numbers are available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Mice lacking the β4 nAChR subunit show less anxiety-like behavior at baseline.
“knockout mice lacking the β4 subunit show less anxiety-like behaviors at baseline (Salas et al. 2003)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Salas et al. 2003 source
The Results report that β4-knockout mice behaved as though they were less anxious in the elevated-plus maze, and the Introduction also cites increased climbing in the staircase maze. But the effect was test-specific: behavior was unchanged in three other tests, and social isolation produced a stronger anxiety-related response. The unqualified claim of less anxiety-like behavior at baseline overgeneralizes those findings. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
The reduced anxiety-like behavior in female α5 knockout mice may be related to progesterone effects on α5 subunit expression.
“and this may be related to progesterone effects on α5 subunit expression (Gangitano et al. 2009)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Gangitano et al. 2009 source
- Premisecitation
The effects of the partial agonist sazetidine could be blocked with mecamylamine.
“the effects of the partial agonist sazetidine could be blocked with mecamylamine (Caldarone et al. 2011)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Caldarone et al. 2011 source
- Premisecitation
Nicotinic partial agonists are effective in mouse models of antidepressant efficacy.
“nicotinic partial agonists, that would be expected to decrease activity of acetylcholine at endogenous nAChRs when cholinergic tone is high but increase activity of nAChRs when cholinergic tone is low, are effective in mouse models of antidepressant efficacy (Mineur et al. 2007(Mineur et al. , 2009b(Mineur et al. , 2011a;;Rollema et al. 2009;Caldarone et al. 2011)”
Quote in the paperSubstantial claim3 of 3 sources checked - Premisecitation
Modulation of nicotinic function through the lynx1 protein is important for regulating the critical period for activity-dependent visual system development.
“modulation of nicotinic function through the lynx1 protein is also important for regulating the critical period for activity-dependent visual system development (Morishita et al. 2010).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Morishita et al. 2010 source
- Premisecitation
Both POMC and NPY neurons express almost all nAChR subunits.
“both POMC and NPY neurons express almost all nAChR subunits”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Calarco et al. 2018 source
The Results section (page not available) detects mRNAs for six nAChR subunits in both POMC and AgRP cell populations, which supports expression of several subunits. It also says α2, α5 and β3 were not reliably detected in either population, so “almost all” overstates the finding. The study measures AgRP rather than NPY neurons specifically, and its Discussion cautions that not every AgRP or POMC cell expresses each subunit. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Nicotine administration during the early postnatal period alters performance in the passive avoidance task in normal mice and in mice with expression of β2 nAChRs exclusively in corticothalamic neurons.
“Nicotine administration during this same period alters performance in the passive avoidance task in normal mice as well as in mice with expression of β2 Ã nAChRs exclusively in corticothalamic neurons (Heath et al. 2010)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Heath et al. 2010 source
The Results section reports that nicotine exposure from birth to weaning altered passive avoidance in mice. It also reports altered performance in mice expressing β2-containing nAChRs exclusively in corticothalamic neurons, but those mice received nicotine throughout gestation as well as postnatally; the paper does not establish the effect of postnatal-only exposure in that group (page not available in our copy). (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
nAChRs on glutamatergic thalamocortical neurons impinging on layer 5 pyramidal neurons in the prefrontal cortex are an important site for nAChR control of attention.
“Studies in rodents have also implicated nAChRs on glutamatergic thalamocortical neurons impinging on layer 5 pyramidal neurons in the prefrontal cortex as an important site for nAChR control of attention (Lambe et al. 2005;Bailey et al. 2010).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Lambe et al. 2005 source
- cites Bailey et al. 2010 source
The Introduction and Discussion support a role for prefrontal nAChRs in attention. But this paper identifies nAChRs on layer VI pyramidal neurons that project from cortex to thalamus; it does not establish the claimed site on thalamocortical neurons impinging on layer 5 pyramidal neurons. No page numbers were provided in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Rapid acetylcholine transients in the mPFC are correlated with attention to brief cues.
“rapid acetylcholine transients in the mPFC are correlated with attention to brief cues”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
Mice lacking the β2, but not the α7, subunit show impaired performance in an attentional task.
“mice lacking the β2, but not the α7, subunit show impaired performance in an attentional task (Parikh et al. 2007(Parikh et al. , 2008)).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Parikh et al. 2007 source
- cites Parikh et al. 2008 source
The Subjects section describes experiments in rats, not mice lacking receptor subunits. The Discussion mentions that an α7-selective antagonist did not impair attentional performance, but does not report the claimed comparison between β2- and α7-deficient mice. Searches for knockout mice and the two subunits found no passage establishing that comparison; page numbers were unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Mice lacking the α7 subunit have impaired trace eye-blink conditioning.
“Mice lacking the α7 subunit have been shown to have impaired trace eye-blink conditioning (Brown et al. 2010).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Brown et al. 2010 source
- Premisecitation
nAChRs play a role in maturation of circuits important for attention during development.
“many studies have shown a role for nAChRs in maturation of circuits important for attention during development (reviewed in Heath and Picciotto 2009).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Heath and Picciotto 2009 source
- Premisecitation
Deletion of the β4 nAChR subunit from either POMC or NPY neurons is sufficient to attenuate nicotinic-induced decreases in food intake.
“deletion of the β4 nAChR subunit from either subtype is sufficient to attenuate nicotinic-induced decreases in food intake (Calarco et al. 2018).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Calarco et al. 2018 source
The Results section (page not provided) reports that β4 knockdown in POMC or AgRP neurons blunted the decrease in food intake caused by nicotine. The cited study used knockdown, not deletion, and tested AgRP neurons rather than identifying the tested population as NPY neurons. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Currents mediated through α5/β2 nAChRs are maximal in the early postnatal period.
“Electrophysiological studies have shown that currents mediated through α5/β2 Ã nAChRs are maximal in the early postnatal period (Kassam et al. 2008).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Kassam et al. 2008 source
The section “Nicotinic currents in layer VI pyramidal neurons change across development” reports that currents in rat prefrontal cortical neurons were highest in the first postnatal month. The paper separately says pharmacological results suggest involvement of α5-containing α4β2 receptors; it does not establish that the measured developmental peak was specifically a peak in currents mediated by that receptor subtype. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Withdrawal from binge eating increases acetylcholine release in the NAc.
“withdrawal from binge eating increases acetylcholine release in the NAc (Avena et al. 2008).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Avena et al. 2008 source
The Results report increased extracellular acetylcholine in the nucleus accumbens after 24–36 hours of fasting in rats that had binged on sucrose and chow. The Abstract interprets the fasting state as resembling opiate-like withdrawal. The claim omits those limits and states the effect for withdrawal from binge eating generally. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
In a slice preparation, the effects of nicotine on firing of POMC neurons persist longer than firing of NPY neurons.
“in a slice preparation, the effects of nicotine on firing of POMC neurons persist longer than firing of NPY neurons (Parikh et al. 2007(Parikh et al. , 2008))”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Parikh et al. 2007 source
- cites Parikh et al. 2008 source
The Methods describe in vivo recordings of cholinergic signals in the medial prefrontal cortex, and the Discussion compares the decay of nicotine- and ABT-089-evoked signals. Searches for POMC, NPY, and slice-based neuronal firing found no passage comparing nicotine’s effects on those neurons. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Interpretationcitation
At the circuit level, stimulation of nAChRs shifts the balance toward neuronal patterns that signal satiety.
“showing that at the circuit level, stimulation of nAChRs shifts the balance toward neuronal patterns that signal satiety (Calarco and Picciotto 2020).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Calarco and Picciotto 2020 source
The 'nAChR Signaling in the ARC' section reports that nicotine increases firing in POMC neurons, which are associated with reduced feeding. But it also increases firing in AgRP neurons, and the paper presents its explanation for reduced food intake as a hypothesis—not a demonstrated shift toward a satiety-associated neuronal pattern. The Figure 3 caption likewise describes both populations as activated by nicotine. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
Local infusion of a nicotinic agonist into the VTA, but not the NAc, is sufficient for nicotine place preference in rats.
“This is consistent with previous studies suggesting that nAChRs within the VTA are critical for nicotine reward, because local infusion of a nicotinic agonist into the VTA, but not the NAc, is sufficient for nicotine place preference in the rat (Museo and Wise 1994).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Museo and Wise 1994 source
- Interpretationreasoning
Molecular genetic studies support that α4/α6/β2* nAChRs on DA neurons in the VTA are essential for nicotine reinforcement.
“Thus, molecular genetic studies support the idea that α4/α6/β2 Ã nAChRs on DA neurons in the VTA are essential for nicotine reinforcement.”
Quote in the paperSubstantial claim - Premisecitation
nAChRs containing the β2 subunit are essential for nicotine to depolarize DA cell bodies in the VTA and increase their firing rate.
“Electrophysiological studies have shown that nAChRs containing the β2 subunit are essential for the ability of nicotine to depolarize DA cell bodies in the VTA and to increase their firing rate (Picciotto et al. 1998;Zhou et al. 2001).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Gain-of-function studies of α6 coupled with α4 knockout show that the predominant receptor mediating DA release from VTA neurons is the α4/α6/β2* subtype.
“Gain-of-function studies of the α6 subunit, coupled with α4 subunit knockout show that the predominant receptor mediating DA release from VTA neurons are of the α4/α6/ β2 Ã subtype (Engle et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Engle et al. 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In a slice preparation, nicotine can potentiate glutamate input to DA neurons through α7 nAChRs, resulting in long-term potentiation of those inputs.
“In a slice preparation, nicotine can potentiate glutamate input to DA neurons through α7 nAChRs, resulting in long-term potentiation of those inputs (Mansvelder and McGehee 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mansvelder and McGehee 2000 source
- Interpretationcitation
Postsynaptic depolarization of DA neurons is essential for behaviors related to nicotine reward and reinforcement such as place preference and self-administration.
“Evidence from mouse genetic models with knockout or mutations of nAChR subunits suggests that the postsynaptic depolarization of DA neurons is essential for behaviors related to nicotine reward and reinforcement such as nicotine place preference and self-administration.”
Quote in the paperSubstantial claim - Interpretationreasoning
Disruption of α5* nAChR signaling diminishes the stimulatory effects of nicotine on MHb-IPN activity and thereby permits greater nicotine consumption.
“Hence, disruption of α5 Ã nAChR signaling diminishes the stimulatory effects of nicotine on MHb-IPN activity, and thereby permits consumption of greater quantities of nicotine.”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine-induced activation of the MHb-IPN pathway produces a negative motivational signal that limits further nicotine intake.
“Nicotineinduced activation of the MHb-IPN pathway results in a negative motivational signal that serves to limit further nicotine intake.”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine activates the MHb-IPN pathway through stimulatory effects on α5* nAChRs.
“Taken together, these findings suggest that nicotine activates the MHb-IPN pathway through stimulatory effects on α5 Ã nAChRs.”
Quote in the paperSubstantial claim - Premisecitation
Approximately 90%-100% of MHb neurons express α3, α4, α5, β2, and β4 nAChR subunits.
“Indeed, approximately 90%-100% of MHb neurons express α3, α4, α5, β2, and β4 nAChR subunits (Sheffield et al. 2000)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sheffield et al. 2000 source
- Premisecitation
Overexpression of β4* nAChRs in mice using BAC transgenic technology resulted in greatly diminished sensitivity to the reinforcing properties of orally consumed nicotine solutions and far less consumption than wild-type mice.
“Specifically, overexpression of β4 Ã nAChRs in mice using BAC transgenic technology resulted in greatly diminished sensitivity to the reinforcing properties of orally consumed nicotine solutions and far less consumption of the drug than wild-type mice (Frahm et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Frahm et al. 2011 source
- Premisecitation
The MHb contains some of the highest densities of nicotine-binding sites in the brain.
“The MHb contains some of the highest densities of nicotine-binding sites in brain (Mugnaini et al. 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mugnaini et al. 2002
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
nAChRs containing α5, α3, and/or α4 subunits, densely expressed in the MHb-IPN pathway, regulate addiction-related actions of nicotine.
“The above findings suggest that nAChRs containing α5, α3, and/or α4 nAChR subunits, densely expressed in the MHb-IPN pathway, regulate addiction-related actions of nicotine.”
Quote in the paperSubstantial claim - Premisecitation
The highest densities of α5, α3, and α4 nAChR subunit expression in the brain are detected in the MHb and/or IPN.
“In particular, the highest densities of α5, α3, and α4 nAChR subunits expression in brain are detected in MHb and/or IPN (De Biasi and Salas 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites De Biasi and Salas 2008 source
- Interpretationreasoning
β4* nAChRs in the MHb-IPN pathway regulate sensitivity to the aversive effects of nicotine that control the quantities consumed.
“This finding suggests that, similar to α5 Ã nAChRs, β4 Ã nAChRs in the MHb-IPN pathway also regulate sensitivity to the aversive effects of nicotine that control the quantities of the drug consumed.”
Quote in the paperSubstantial claim - Premisecitation
Withdrawal duration and severity predict relapse in abstinent human smokers.
“Indeed, withdrawal duration and severity predict relapse in abstinent human smokers (Piasecki et al. 1998(Piasecki et al. , 2000(Piasecki et al. , 2003)).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
The nicotine withdrawal syndrome in abstinent smokers comprises somatic and affective components.
“The nicotine withdrawal syndrome in abstinent smokers is comprised of”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
TCF7L2 acts downstream from GLP-1 receptor-mediated transmission to regulate the function of habenular nAChRs and thereby control nicotine intake.
“Taken together, these observations suggest TCF7L2 acts downstream from GLP-1 receptor-mediated transmission to regulate the function of habenular nAChRs and thereby control nicotine intake.”
Quote in the paperSubstantial claim- Rests on an assumption: GLP-1 receptors are Gs-coupled G-protein-coupled receptors that enhance cAMP production.
- Rests on an assumption: In pancreatic β cells, GLP-1-stimulated increases in cAMP cause phosphorylation and nuclear translocation of β-catenin, which dimerizes with TCF7L2.
- Premisecitation
Affective symptoms of nicotine withdrawal primarily include depressed mood with anhedonia, dysphoria, anxiety, irritability, difficulty concentrating, and craving.
“Affective symptoms primarily include depressed mood including anhedonia, dysphoria, anxiety, irritability, difficulty concentrating, and craving (Parrott 1993;Doherty et al. 1995;Kenny and Markou 2001).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
GLP-1 released from NTS inputs to the IPN stimulates terminals of MHb cholinergic neurons to enhance excitatory transmission onto IPN neurons and inhibit nicotine intake.
“These findings suggest that GLP-1, released from NTS inputs to IPN, stimulates the terminals of MHb cholinergic neurons to enhance excitatory transmission onto IPN neurons to inhibit nicotine intake.”
Quote in the paperSubstantial claim - Premisecitation
Direct infusion of mecamylamine into the IPN, but not the VTA, of nicotine-dependent wild-type mice precipitated somatic withdrawal signs.
“Moreover, direct infusion of mecamylamine into the IPN, but not the VTA, of nicotinedependent wild-type mice precipitated the expression of somatic withdrawal signs (Salas et al. 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Salas et al. 2009 source
- Interpretationreasoning
α5* and α2* nAChRs in the MHb-IPN pathway, and perhaps other subtypes enriched there, regulate the expression of somatic signs of nicotine withdrawal.
“This suggests that α5 Ã and α2 Ã nAChRs in the MHb-IPN pathway, and perhaps other nAChR subtypes enriched in this pathway, regulate the expression of somatic signs of nicotine withdrawal.”
Quote in the paperSubstantial claim - Premisecitation
α5 and α2 subunit knockout mice made dependent on nicotine did not show somatic signs of nicotine withdrawal when withdrawal was precipitated with mecamylamine.
“α5 and α2 subunit knockout mice that were dependent on nicotine (delivered through subcutaneously implanted osmotic minipumps) did not show somatic signs of nicotine withdrawal when withdrawal was precipitated with the nAChR antagonist mecamylamine (Salas et al. 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Salas et al. 2009 source
- Premisecitation
The most common somatic symptoms of nicotine withdrawal include bradycardia, gastrointestinal discomfort, and increased appetite.
“The most common somatic symptoms include bradycardia, gastrointestinal discomfort, and increased appetite.”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Some of the highest densities of GLP-1 receptor binding sites in the brain are detected in the IPN.
“Notably, some of the highest densities of GLP-1 receptor binding sites in the brain are detected in the IPN (Göke et al. 1995).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Göke et al. 1995
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
α5 and β4, and perhaps α2 and α3, nAChRs enriched in the MHb-IPN pathway play a key role in regulating nicotine reinforcement and the expression of nicotine withdrawal syndrome in nicotine-dependent rodents.
“The above findings support a key role for α5 and β4, and perhaps also α2 and α3 nAChRs, which are enriched in the MHb-IPN pathway in regulating nicotine reinforcement and the expression of the nicotine withdrawal syndrome in nicotine-dependent rodents.”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine stimulates GLP-1 neurons in the NTS via α5* nAChRs, which in turn enhances activity of the MHb-IPN pathway to inhibit nicotine intake.
“Taken together, these findings suggest that nicotine stimulates GLP-1 neurons in NTS via a5 Ã nAChRs, which in turn enhances the activity of the MHb-IPN pathway to inhibit nicotine intake.”
Quote in the paperSubstantial claim - Interpretationreasoning
GLP-1 released from NTS neurons may regulate activity of the MHb-IPN pathway to control nicotine intake.
“This suggests that GLP-1 released from NTS neurons may regulate activity of the MHb-IPN pathway to control nicotine intake.”
Quote in the paperSubstantial claim - Premisecitation
The behavioral effects of increased hippocampal ACh signaling mirror the increased depressive symptoms observed in human subjects administered an AChE antagonist.
“This mirrors the increased depressive symptoms observed in human subjects administered an AChE antagonist (Risch et al. 1981)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Risch et al. 1981
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Stimulation of α5β4 nAChRs is important for the anxiogenic effects of nicotine.
“These data suggest that stimulation of α5β4 Ã nAChRs is important for the anxiogenic effects of nicotine.”
Quote in the paperSubstantial claim - Premisecitation
Mecamylamine is effective as an add-on medication in depressed human subjects who are nonresponsive to an SSRI.
“is effective as an add-on medication in depressed human subjects who are nonresponsive to a selective serotonin reuptake inhibitor (SSRI) (George et al. 2008)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites George et al. 2008 source
- Interpretationreasoning
The anxiolytic and anxiogenic effects of nicotine are likely mediated by different nAChR subtypes.
“and these effects are likely to depend on different nAChR subtypes.”
Quote in the paperSubstantial claim - Premisecitation
Mice lacking the α7 nAChR subunit are resistant to the antidepressant-like effects of mecamylamine.
“mice lacking the α7 subunit are also resistant to the antidepressant-like effects of mecamylamine (Rabenstein et al. 2006)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rabenstein et al. 2006 source
- Interpretationreasoning
β2 nAChRs are critical for the antidepressant-like effects of nicotinic drugs.
“suggesting that β2 Ã nAChRs are critical for the antidepressant-like effects of nicotinic drugs.”
Quote in the paperSubstantial claim - Interpretationreasoning
ACh-serotonin interactions can contribute to dysphoric effects of ACh signaling mediated through the hippocampus.
“suggesting that ACh-serotonin interactions can contribute to dysphoric effects of ACh signaling mediated through this structure.”
Quote in the paperSubstantial claim - Interpretationreasoning
Other nAChR subtypes may also contribute to the antidepressant-like effects of nicotinic drugs.
“suggesting that other nAChR subtypes may also contribute to the antidepressant-like effects of nicotinic drugs”
Quote in the paperSubstantial claim - Interpretationreasoning
Activation as well as inhibition of nAChRs can show antidepressant-like effects.
“and that activation as well as inhibition of nAChRs can show antidepressant-like effects.”
Quote in the paperSubstantial claim - Premisecitation
Mecamylamine has antidepressant-like effects in mice.
“the nicotinic antagonist mecamylamine has antidepressantlike effects in mice (Caldarone et al. 2004;Rabenstein et al. 2006;Andreasen et al. 2009)”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
nAChR subtypes regulate baseline activity of the basolateral amygdala (BLA).
“nAChR subtypes regulate baseline activity of the basolateral amygdala (BLA)”
Quote in the paperSubstantial claim - Interpretationreasoning
Activation of nAChRs decreases depression-like behavior in the Flinders-sensitive rat model.
“suggesting that activation of nAChRs de-creases depression-like behavior in this model (Tizabi et al. 2000)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tizabi et al. 2000 source
- Premisecitation
Acute nicotine administration is antidepressant-like in the forced swim test in Flinders-sensitive rats.
“acute nicotine administration is antidepressant-like in the forced swim test”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tizabi et al. 2000 source
- Interpretationreasoning
The cycles of nAChR activation and desensitization experienced by smokers may result in fluctuations in depressive symptoms throughout the day.
“so the cycles of nAChR activation and desensitization experienced by smokers may result in fluctuations in depressive symptoms throughout the day.”
Quote in the paperSubstantial claim - Premisecitation
5HT1a serotonin receptors in the hippocampus are required for antidepressant-like effects of nicotinic compounds.
“5HT1a serotonin receptors in hippocampus are required for antidepressantlike effects of nicotinic compounds (Mineur et al. 2015)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur et al. 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Decreasing nAChR activity in the BLA can induce resilience to stress, even in animals with no manipulation of ACh activity.
“and decreasing their activity can induce resilience to stress, even in animals with no manipulation of ACh activity.”
Quote in the paperSubstantial claim - Premisecitation
Some estimates suggest that about 44% of cigarettes are sold to individuals with a current psychiatric condition.
“and some estimates suggest that ∼44% of cigarettes are sold to individuals with a current psychiatric condition (Lasser et al. 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lasser et al. 2000 source
- Interpretationreasoning
Inhibition of nAChRs in some neuronal subtypes or brain areas and activation in others may contribute to an antidepressant-like effect of nicotinic drugs.
“These data suggest that inhibition of nAChRs in some neuronal subtypes or brain areas and activation in others may contribute to an antidepressant-like effect of nicotinic drugs”
Quote in the paperSubstantial claim - Premisenone given
β2 knockout mice show decreased depression-like behavior at baseline.
“and these knockout mice show decreased depression-like behavior at baseline”
Quote in the paperSubstantial claim - Premisecitation
Local knockdown of the α7 nAChR subunit in the hippocampus greatly attenuated the anxiogenic and social interaction phenotypes induced by AChE blockade.
“Local knockdown of the α7 nAChR subunit in the hippocampus greatly attenuated the anxiogenic and social interaction phenotypes induced by AChE blockade (Mineur et al. 2018a)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur et al. 2018a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The antidepressant-like effect of acute nicotine in Flinders-sensitive rats can be blocked by mecamylamine.
“this effect can be blocked by the nicotinic antagonist mecamylamine”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tizabi et al. 2000 source
- Premisecitation
Expression of β2 nAChRs in the BLA is necessary for the antidepressant-like effects of the noradrenergic agonist guanfacine.
“Expression of β2 Ã nAChRs in the BLA is necessary for the antidepressant-like effects of the noradrenergic agonist guanfacine”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur et al. 2018b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
ACh-norepinephrine interactions are important for regulation of BLA activity and associated stress-induced behaviors.
“suggesting that ACh-norepinephrine interactions are important for regulation of BLA activity and associated stress-induced behaviors (Mineur et al. 2018b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur et al. 2018b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
β4 nAChRs on proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus are necessary for the appetite-suppressing effects of nicotine.
“β4 Ã nAChRs on proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus are necessary for the appetite-suppressing effects of nicotine (Mineur et al. 2011b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur et al. 2011b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Disrupting normal acetylcholine signaling through these nAChRs during a critical period has lasting effects on the function of the corticothalamic circuit in passive avoidance behavior.
“suggesting that disrupting normal acetylcholine signaling through these nAChRs during a critical period has lasting effects on the function of the corticothalamic circuit in passive avoidance behavior.”
Quote in the paperSubstantial claim - Premisecitation
β2 nAChRs in the prelimbic medial prefrontal cortex are important for normal performance of the 5-choice serial reaction time task measuring visual attention.
“Studies using knockout mice with lentiviralmediated reexpression have shown that β2 Ã nAChRs in the prelimbic medial prefrontal cortex (mPFC) are important for normal performance of the 5-choice serial reaction time task measuring visual attention.”
Quote in the paperNot a substantial claim- Rests on an assumption: β2 nAChRs in the prelimbic medial prefrontal cortex are important for normal performance of the 5-choice serial reaction time task measuring visual attention.
- Premisecitation
Nicotine decreases feeding in animal models.
“nicotine decreases feeding in animal models (Grunberg et al. 1987)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Grunberg et al. 1987 source
- Premisecitation
α7 nAChRs are implicated in prepulse inhibition, a physiological marker associated with schizophrenia.
“Genetic and functional studies have implicated α7 nAChRs in prepulse inhibition, a physiological marker associated with schizophrenia (Leonard et al. 2000;Freedman et al. 2003).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given
β2α4α6 nAChRs are critical for nicotine reward and reinforcement.
“Whereas β2α4α6 Ã nAChRs are critical for nicotine reward and reinforcement”
Quote in the paperNot a substantial claim- Rests on an assumption: β2α4α6 nAChRs are critical for nicotine reward and reinforcement.
- Premisecitation
Nicotine and nicotinic drugs can improve attention in individuals with schizophrenia.
“and individuals with schizophrenia (Sacco et al. 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sacco et al. 2004
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
After control subjects quit smoking and transition past the acute withdrawal period, their working memory function improves compared with when they were smoking.
“after control subjects quit smoking and transition past the acute withdrawal period, their working memory function improves compared with when they were smoking (George et al. 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites George et al. 2002
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Individuals with schizophrenia show impaired performance once they quit smoking.
“individuals with schizophrenia show impaired performance once they quit smoking (George et al. 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites George et al. 2002
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The principal reason cited by female teenagers for why they smoke is weight control.
“the principal reason cited by female teenagers for why they smoke is weight control (Voorhees et al. 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Voorhees et al. 2002 source
- Premisecitation
The anorexic effects of smoking have been well-documented in human subjects.
“The anorexic effects of smoking have been welldocumented in human subjects”
Quote in the paperNot a substantial claim- Rests on an assumption: The anorexic effects of smoking have been well-documented in human subjects.
- Interpretationcitation
The nicotine in tobacco is important for the effects of smoking on appetite.
“suggesting that the nicotine in tobacco is important for the effects of smoking on appetite.”
Quote in the paperSubstantial claim - Premisecitation
There are a number of nAChR subtypes expressed in the hypothalamus.
“There are a number of nAChR subtypes expressed in the hypothalamus (Jo et al. 2002(Jo et al. , 2005))”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Jo et al. 2002
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Jo et al. 2005
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Increased ACh signaling can lead to symptoms of depression and anxiety in human subjects and mouse models.
“The observation that increased ACh signaling can lead to symptoms of depression and anxiety in human subjects and mouse models”
Quote in the paperSubstantial claim - Premisecitation
Nicotine and nicotinic drugs can improve attention in control subjects.
“nicotine and nicotinic drugs can improve attention in control subjects (Rusted and Warburton 1992)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rusted and Warburton 1992 source
- Interpretationnone given
Incorporation of α6 and β3 nAChR subunits in α4β2 nAChRs in the mesoaccumbens pathway gives rise to an nAChR subtype (α4α6β2β3) that appears to play a particularly important role in nicotine reinforcement.
“incorporation of α6 and β3 nAChR subunits in α4β2 Ã nAChRs in the mesoaccumbens pathway gives rise to an nAChR subtype (α4α6β2β3 Ã ) that appears to play a particularly important role in nicotine reinforcement.”
Quote in the paperNot a substantial claim - Interpretationnone given
High-affinity α4β2 nAChRs play a key role in the behavioral actions of nicotine that contribute to the development of tobacco dependence, including its effects on brain circuitries involved in reinforcement, mood, attention, and food consumption.
“The high-affinity α4β2 Ã nAChRs play a key role in the behavioral actions of nicotine that contribute to the development of tobacco dependence, including its effects on brain circuitries involved in reinforcement, mood, attention, and food consumption.”
Quote in the paperNot a substantial claim - Premisecitation
The DA system is important for the hedonic value of both drugs of abuse, like nicotine, and palatable foods.
“The DA system is important for the hedonic value of both drugs of abuse, like nicotine, and palatable foods (Kenny 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kenny 2011 source
- Interpretationreasoning
nAChRs in the mesolimbic DA system may be more important for the motivation to work for food.
“nAChRs in the mesolimbic DA system may be more important for the motivation to work for food.”
Quote in the paperSubstantial claim - Interpretationnone given
β4 nAChRs also play an important role in appetite regulation, particularly the inhibitory effects of nicotine on appetite that underlie the anorectic effects of tobacco smoke.
“β4 Ã nAChRs also play an important role in appetite regulation, particularly the inhibitory effects of nicotine on appetite that underlie the anorectic effects of tobacco smoke.”
Quote in the paperNot a substantial claim - Premisecitation
Food or sugar intake can increase acetylcholine release in the VTA.
“Food or sugar intake can increase acetylcholine release in the VTA (Hajnal et al. 1998;Rada et al. 2000)”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Blocking α7 nicotinic AChRs in the VTA can decrease food seeking.
“blocking α7 nicotinic AChRs in the VTA can decrease food seeking (Schilström et al. 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schilström et al. 1998 source
- Premisenone given
β4 nAChRs on POMC neurons can signal satiety.
“Although β4 Ã nAChRs on POMC neurons can signal satiety”
Quote in the paperNot a substantial claim- Rests on an assumption: β4 nAChRs on POMC neurons can signal satiety.
- May combine two claims. 46
- Classified as probably not a substantial claim. 3
May combine two claims.
PremisecitationDA neurons express heteromeric nAChRs containing α4, α5, α6, β2, and β3 subunits in various combinations, with predominant subtypes being α4/β2/α5 and α4/α6/β2/β3.
“DA neurons express heteromeric nAChRs containing the α4, α5, α6, β2, and β3 subunits in various combinations, with the predominant subtypes being α4/β2/α5 and α4/α6/ β2/β3.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Klink et al. 2001 source
In “The DA subtypes” (page unavailable), the paper proposes an α4/α5/β2 receptor, supporting one named subtype. But it proposes α4/α6/α5/β2—not α4/α6/β2/β3—for the other, and explicitly suggests that β3 does not enter DA somatodendritic receptors. The paper also describes these compositions as putative, rather than established. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites Zoli et al. 2002 source
The section on striatal receptor populations identifies α4, α5, α6, β2, and β3 in receptors on dopaminergic terminals. But it estimates four major populations: α4β2 and α4β2α5 at about 30% each, α6β2(β3) at about 25%, and α4α6β2(β3) at about 15%. Thus it does not support calling α4β2α5 and α4α6β2β3 the two predominant subtypes; β3 is also shown as optional in the latter composition. Page numbers were not provided in the passages. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn mice with constitutive α6 knockout, intra-VTA self-administration of nicotine is not disrupted, whereas α4* nAChRs are necessary and sufficient for intra-VTA self-administration and nicotine-induced increases in DA neuron firing.
“In contrast, in mice with constitutive knockout of the α6 subunit, intra-VTA selfadministration of nicotine is not disrupted, whereas α4 Ã nAChRs are necessaryand sufficient for both intra-VTA self-administration, as well as nicotine-induced increases in firing of DA neurons (Exley et al. 2011;McGranahan et al. 2011).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Exley et al. 2011 source
The Results (page unavailable) show that α6-knockout mice self-administered intra-VTA nicotine similarly to wild-type mice at 100 ng, but less at 10 ng. They also show that α4 deletion prevented sustained self-administration and eliminated nicotine-induced bursting, not all increases in DA-neuron firing rate. Targeted α4 re-expression only partially restored the firing response and did not fully restore long-term self-administration, so the claim that α4* receptors are sufficient for both outcomes overstates the findings. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites McGranahan et al. 2011 source
The Results section, “α4*-nAChRs on Dopaminergic Neurons Mediate Nicotine Reward” (page unavailable), shows that deleting α4 from dopamine neurons abolished nicotine conditioned place preference, supporting a role for α4* receptors in nicotine reward. The Discussion, “Nicotine CPP is Mediated by Dopaminergic α4*-nAChRs” (page unavailable), reports that nicotine-stimulated dopamine-neuron burst firing requires α4β2* receptors. This paper does not establish the stated findings about α6-knockout mice, intra-VTA nicotine self-administration, or sufficiency of α4* receptors for self-administration and increased firing. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Interpretationcitationα4 and α6 subunits are both required for nicotine to gate DA transmission in the NAc, suggesting that nAChRs in the NAc may be more important in motivation to self-administer nicotine and may affect acquisition of self-administration and nicotine-dependent locomotor activation.
“However, α4 and α6 subunits are both required for the ability of nicotine to gate DA transmission in the NAc, suggesting that nAChRs in NAc may be more important in motivation to self-administer nicotine (Brunzell et al. 2010;Exley et al. 2011) and that this may affect acquisition of self-administration behavior (Pons et al. 2008;Gotti et al. 2010), as well as nicotine-dependent locomotor activ”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Brunzell et al. 2010 source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites Exley et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Pons et al. 2008 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe habenula is a diencephalic structure on the dorsomedial surface of the caudal thalamus, segregated into medial and lateral domains.
“The habenula is a diencephalic structure located on the dorsomedial surface of the caudal thalamus that is segregated into medial (MHb) and lateral (LHb) domains (Lecourtier and Kelly 2007;Hikosaka 2010).”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe LHb projects densely to the RMTg and has a well-established inhibitory effect on midbrain DA neuron firing.
“In particular, the LHb projects densely to the rostromedial tegmental nucleus (RMTg) (Jhou et al. 2009), and has a well-established inhibitory effect on the firing of midbrain DA neurons (Lecourtier and Kelly 2007;Matsumoto and Hikosaka 2009;Hikosaka 2010;Bromberg-Martin and Hikosaka 2011).”
Quote in the paperSubstantial claim2 of 3 sources checkedMay combine two claims.
PremisecitationExpression of a hypersensitive α6 subunit in a BAC transgenic mouse line potentiates nicotine-induced burst firing in DA neurons and potentiates nicotine place preference at low doses.
“Similarly, expression of a hypersensitive α6 subunit in a bacterial artificial chromosome (BAC) transgenic mouse line potentiates nicotine-induced burst firing in DA neurons, and potentiates nicotine place preference at low doses of nicotine (Drenan et al. 2008a(Drenan et al. , 2010)).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Drenan et al. 2008a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Drenan et al. 2010 source
The Results (α6α4* nAChR-mediated locomotion and behavioral analysis; page unavailable) identify the hypersensitive α6L9′S BAC mouse line. The Results (Burst firing selectively increases DA release in α6L9′S dorsal striatum; page unavailable) report that nicotine increases DA-neuron firing, but only suggest that it may increase burst firing. Our copy does not report nicotine place preference at low doses; its low-dose behavioral finding concerns locomotor activation. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationLHb neurons are excited by omission of anticipated rewards or exposure to aversive stimuli.
“LHb neurons are excited by omission of anticipated rewards or exposure to aversive stimuli (Lecourtier and Kelly 2007;Matsumoto and Hikosaka 2009;Hikosaka 2010;Bromberg-Martin and Hikosaka 2011).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Lecourtier and Kelly 2007 source
- cites Matsumoto and Hikosaka 2009 source
- cites Hikosaka 2010 source
The Avoidance of punishment section reports that LHb neurons are excited by aversive stimuli, and the Reward-based decision-making section reports excitation by cues predicting a small reward. The paper also describes LHb reward-prediction-error signals, but the passages do not establish excitation specifically when an anticipated reward is omitted; a cue predicting no reward is not the same as an unexpected omission. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationConotoxins selective for α6/β2* nAChRs disrupt nicotine self-administration in rats when infused into the VTA and decrease motivation to lever press for nicotine on a progressive ratio schedule after training.
“Similarly, conotoxins selective for α6/β2 Ã nAChRs disrupt nicotine self-administration in the rat when infused into the VTA (Gotti et al. 2010) and following selfadministration training, these conotoxins decrease the motivation to lever press for nicotine on a progressive ratio schedule (Brunzell et al. 2010).”
Quote in the paperSubstantial claim2 of 2 sources checkedMay combine two claims.
InterpretationreasoningGenetic variability in CHRNA5 is a major risk factor for lung cancer and COPD in smokers, likely reflecting higher tobacco dependence and greater exposure to carcinogens and toxins.
“In addition, the same genetic variability in CHRNA5 is also a major risk factor for lung cancer and chronic obstructive pulmonary disease (COPD) in smokers (Amos et al. 2008;Hung et al. 2008;Wang et al. 2010), likely reflecting higher levels of tobacco dependence in individuals carrying risk alleles and consequently greater exposure to carcinogens and”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Amos et al. 2008 source
The Abstract reports that variants in a region containing CHRNA5 are associated with lung cancer risk in ever-smokers. It does not establish CHRNA5 specifically as the causal gene or address COPD. Its smoking-behavior analysis found only weak evidence of an effect on dependence and says the lung-cancer association persisted after adjustment for smoking exposure, so it does not support the proposed explanation of greater carcinogen exposure. (LLM, conf=0.89)
Experimental — accuracy not yet measured - cites Hung et al. 2008 source
The main text identifies a CHRNA5 variant among the markers most strongly associated with lung cancer, including in smokers. Our copy does not report a COPD association. The Supplementary Discussion says the authors found no association with their nicotine-dependence measures and considered tobacco addiction an unlikely explanation for the lung-cancer association, contrary to the proposed mechanism. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites Wang et al. 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationIncreased risk of tobacco dependence is associated with rs6495308, rs578776, or rs1051730 in CHRNA3, and with rs1948 in CHRNB4.
“In addition to the rs16969968 SNP in CHRNA5, there is also increased risk of tobacco dependence in individuals carrying the rs6495308, rs578776, or rs1051730 SNPs in CHRNA3 (Berrettini et al. 2008;Saccone et al. 2009), and rs1948 in CHRNB4 (Schlaepfer et al. 2008).”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites Berrettini et al. 2008 source
Table 2 (p. 2) identifies rs6495308 in CHRNA3 as associated with cigarettes smoked per day, which the paper uses as a measure relevant to nicotine dependence. Our copy does not identify rs578776 or rs1051730 as associated risk variants. The rs1948 claim is attached to Schlaepfer et al., not to Berrettini et al., so it is outside this citation assessment. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites Saccone et al. 2009 source
The Discussion and Conclusions (page unavailable) report an association with nicotine dependence for rs6495308 (OR 1.29), and the Results identify the major allele of rs578776 as a risk allele. The paper discusses rs1051730 as correlated with the dependence-associated locus, but gives its SNP-specific association figures for lung cancer, not tobacco dependence. The rs1948 claim is cited to Schlaepfer et al., not to this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Schlaepfer et al. 2008 source
The Results and Discussion report that the CC genotype of rs1948 in CHRNB4 predicts earlier tobacco initiation, including in a replication sample. They do not establish increased risk of tobacco dependence for rs1948. The other SNPs in the citing sentence are attributed to different sources, not to Schlaepfer et al. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationElectrophysiological studies show that α3 and β4 levels are strong throughout the ventral MHb, while α6, β2, β3, and α4 subunits are selectively found in some but not all of these neurons.
“Electrophysiological studies have shown that, whereas α3 and β4 nAChR subunit levels are strong throughout the ventral MHb, α6, β2, β3, and α4 subunits are selectively found in some, but not all of these neurons (Shih et al. 2014).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Shih et al. 2014 source
The Results report strong, even α3 and β4 localization throughout ventral MHb and regional differences for α4, α6, β2, and β3. But β2 immunoreactivity is reported throughout ventral MHb, and β3 is weak—not absent—in its lateral portion, so the claim that each is found in some but not all of these neurons overstates the evidence. The subunit-localization findings came from staining, although the study also used electrophysiology. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe CHRNA5 SNP rs16969968 increases risk of tobacco dependence by about 30% in individuals carrying one copy and more than doubles risk in those carrying two risk alleles.
“For example, a singlenucleotide polymorphism (SNP) in CHRNA5 (rs16969968), which is very common in those of European descent (minor allele frequency = 0.42), increases the risk of tobacco dependence by ∼30% in individuals carrying a single copy of the variant, and more than doubles the risk in those carrying two risk alleles (Bierut et al. 2008;Wang et al. 2009); this finding has been consistently”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Bierut et al. 2008 source
The Results (page unavailable) associate CHRNA5 rs16969968 with habitual versus light smoking, and the Discussion says the variant increases susceptibility to nicotine dependence. Our copy does not give the claimed risk increases of about 30% for one copy or more than twofold for two copies; a search for genotype-specific risk estimates did not find them. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Wang et al. 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThe rs16969968 risk variant is associated with heavy smoking, early onset of smoking behavior, and a pleasurable buzz from tobacco.
“The rs16969968 risk variant is associated with heavy smoking (Berrettini et al. 2008;Bierut et al. 2008;Grucza et al. 2008;Stevens et al. 2008), early onset of smoking behavior (Weiss et al. 2008), and with a”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Berrettini et al. 2008 source
The Results (p. 3) associate a CHRNA3–CHRNA5 haplotype with cigarettes per day, supporting the heavy-smoking association at the haplotype level. The Discussion (p. 5) says rs16969968 itself was not genotyped in this paper's studies, so it does not establish that specific variant's association with heavy smoking. The printed citation attaches Berrettini et al. to heavy smoking, not to the separately cited early-onset claim or the buzz claim. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites Bierut et al. 2008 source
- cites Grucza et al. 2008 source
May combine two claims.
PremisecitationNicotine but not food intake was increased in GLP-1 receptor knockout mice.
“Conversely, nicotine but not food intake was increased in GLP-1 receptor knockout mice (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
May combine two claims.
PremisecitationNicotine induces robust and dose-dependent increases in Fos immunoreactivity in NTS neurons, with this effect restricted almost to neurons expressing GLP-1.
“It was shown that nicotine induces robust and dose-dependent increases in Fos immunoreactivity in NTS neurons, with this effect restricted almost neurons that express the neuropeptide glucagon-like peptide-1 (GLP-1) (Tuesta et al. 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
The Results section, “Nicotine activates GLP-1 neurons in the NTS” (page unavailable), reports increased Fos-positive NTS cells after nicotine at two doses, including GLP-1-positive neurons. It does not establish a dose-dependent increase in the quoted passage, and it says a sizable fraction of Fos-positive NTS neurons were not GLP-1-positive, contrary to the claim of near-restriction to GLP-1 neurons. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Rests on an assumption: α5, α3, and β4 nAChR subunits are densely expressed in the nucleus of the solitary tract in the hindbrain.
May combine two claims.
PremisecitationGLP-1 neurons express α5 nAChR subunits, suggesting that nicotine's stimulatory effects on GLP-1 neurons are mediated at least in part by α5* nAChRs.
“Using a line of Chrna5-tdTomato reporter mice, GLP-1 neurons were shown to express α5 nAChR subunits (Tuesta et al. 2017), suggesting that the stimulatory effects of nicotine on GLP-1 neurons is mediated at least in part by α5 Ã nAChRs.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Tuesta et al. 2017 source
The Results section, “Nicotine activates GLP-1 neurons in the NTS” (page not provided), reports GLP-1-positive neurons with α5 reporter expression and suggests that α5* nAChRs on these neurons are activated by nicotine. However, the cited study used Chrna5-EGFP mice, not the Chrna5-tdTomato reporter mice named in the citing sentence; the Methods section, “Animals” (page not provided), confirms this distinction. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Rests on an assumption: α5, α3, and β4 nAChR subunits are densely expressed in the nucleus of the solitary tract in the hindbrain.
May combine two claims.
PremisecitationA large proportion of smokers report smoking to control symptoms of anxiety and depression, and the rate of smoking in individuals with affective disorders is more than double the general population rate.
“Similarly, a large proportion of smokers report that they smoke to control symptoms of anxiety and depression (Picciotto et al. 2002), and the rate of smoking in individuals with affective disorders is more than double the rate in the general population (Kalman et al. 2005).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Picciotto et al. 2002 source
- cites Kalman et al. 2005 source
Only the smoking-rate clause is attributed to Kalman et al.; the claim about smoking to control symptoms cites Picciotto et al. The Abstract reports a general-population rate of about 23% and smoking rates of 55–70% in bipolar disorder, supporting a more-than-double comparison for bipolar disorder. But it reports 40–60% for major depression, so more than double is not supported across the full reported range of affective disorders. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMecamylamine, sazetidine, and amitriptyline are ineffective in mice lacking the β2 nAChR subunit.
“Both the antagonist mecamylamine (Rabenstein et al. 2006) and the partial agonist sazetidine (Caldarone et al. 2011), as well as the classical antidepressant amitriptyline (Caldarone et al. 2004), are ineffective in mice lacking the β2 subunit”
Quote in the paperSubstantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationMice lacking the β2 nAChR subunit show no difference in anxiety-like behavior at baseline or after nicotine administration.
“no difference in anxiety-like behaviors were seen at baseline or following nicotine administration in mice lacking the β2 subunit (Caldarone et al. 2008)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Caldarone et al. 2008 source
May combine two claims.
PremisecitationNicotine can stimulate the firing of both POMC neurons that signal satiety and neuropeptide Y (NPY) neurons that stimulate food seeking.
“nicotine can stimulate the firing of both POMC neurons that signal satiety, and neuropeptide Y (NPY) neurons that stimulate food seeking (Parikh et al. 2007(Parikh et al. , 2008)).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Parikh et al. 2007 source
- cites Parikh et al. 2008 source
The Discussion describes nicotine-evoked neurotransmitter activity in the prefrontal cortex, not firing of POMC or NPY neurons. Searches for POMC, NPY, satiety, food seeking, and hypothalamic feeding found no passage in our copy addressing the attributed claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
InterpretationcitationOptimal levels of ACh contribute to encoding of both rewarding and aversive stimuli, while suprathreshold increases in ACh signaling favor encoding of aversive stimuli and lead to the negative encoding bias observed in anxiety and depressive disorders.
“One possibility is that whereas optimal levels of ACh con-tribute to encoding of both rewarding and aversive stimuli, suprathreshold increases in ACh signaling, mediated by chronic stress or other stimuli that can lead to depression, favor encoding of aversive stimuli and lead to the type of negative encoding bias observed in human subjects with anxiety and depressive disorders (Mineur and Picciot”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Mineur and Picciotto 2019 source
May combine two claims.
Premisecitationα5/β2 nAChRs on layer 6 cortical glutamatergic projection neurons to the thalamus are essential in maturation of this circuit and for normal adult performance in passive avoidance.
“α5/ β2 Ã nAChRs on layer 6 cortical glutamatergic projection neurons to the thalamus are essential in maturation of this circuit and for normal adult performance in passive avoidance, a somatosensory aversive learning task (King et al. 2003;Heath et al. 2010).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites King et al. 2003 source
The Functional characterization section identifies β2-containing receptors on glutamatergic layer VI neurons projecting to the thalamus, and the Developmental expression section links their developmental expression to adult passive-avoidance performance (page numbers unavailable). The Discussion suggests they can affect synaptic maturation, but does not establish that they are essential for circuit maturation. The cited passages do not establish an α5 subunit role. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Heath et al. 2010 source
The Discussion (page unavailable) states that corticothalamic neurons must express β2 and α5 subunits for normal passive avoidance performance. It also says the knockout results suggest an α5-mediated current is important for normal circuit maturation, but does not establish that these receptors are essential for maturation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationKnockdown of either α7 or β2 nAChR subunits in the BLA decreases cFos immunoreactivity and attenuates avoidance of anxiogenic stimuli, immobility in response to inescapable stress, and avoidance after social defeat.
“knockdown of either α7 or β2 nAChR subunits in BLA decreases cFos immunoreactivity in the structure and attenuates avoidance of anxiogenic stimuli, immobility in response to inescapable stress, and avoidance after social defeat (Mineur et al. 2016).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Mineur et al. 2016 source
In the section on downregulation of α7 and β2* receptors, both knockdowns reduced dark-compartment time and tail-suspension immobility. But only β2 knockdown significantly reduced c-fos immunoreactivity and increased social interaction after social defeat; α7 knockdown did neither. The claim incorrectly extends those two effects to both subunits. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationLesions of the VTA and its primary projection area, the NAc, greatly attenuate nicotine self-administration and the psychostimulant properties of nicotine.
“Lesions of the ventral tegmental area (VTA) and its primary projection area, the nucleus accumbens (NAc), greatly attenuate nicotine self-administration and the psychostimulant properties of nicotine”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe MHb contains neurons that produce acetylcholine or substance P, and a small population that produces interleukin-18.
“MHb is comprised of neurons that produce the neurotransmitters acetylcholine (ACh) or substance P (Cuello et al. 1978;Eckenrode et al. 1987), and a small population that produce the cytokine interleukin-18 (IL-18) (Sugama et al. 2002).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationSelective viral reexpression of β2* or α4* nAChRs in the VTA is sufficient to support intra-VTA and systemic nicotine self-administration, identifying subtypes necessary for nicotine reinforcement and showing the importance of nAChRs within the VTA.
“Selective viral reexpression of β2 Ã (Maskos et al. 2005;Pons et al. 2008) or α4 Ã nAChRs in the VTA is sufficient to support both intra-VTA (Maskos et al. 2005) and systemic nicotine self-administration (Pons et al. 2008), identifying the nAChR subtypes necessary for nicotine reinforcement, as well as showing the importance of nAChRs within the VTA itself for this behavior.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationKnockin of a hypersensitive α4 subunit shifts the dose-response curve for nicotine-induced increases in DA neuron firing to the left and results in nicotine place preference at very low doses.
“Conversely, knockin of a hypersensitive α4 subunit shifts the dose-response curve for nicotine-induced increases in DA neuron firing to the left, and results in nicotine place preference at very low doses of the drug (Tapper et al. 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tapper et al. 2004 source
May combine two claims.
PremisecitationKnockout of the α7 subunit in mice does not affect nicotine place preference or acquisition of nicotine self-administration.
“Despite its contribution to nicotine-dependent plasticity in the VTA, knockout of the α7 subunit in mice does not affect nicotine place preference (Walters et al. 2006) or acquisition of nicotine self-administration (Pons et al. 2008).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAntagonizing α7 type nAChRs in the NAc or anterior cingulate cortex in rats increases motivation to self-administer nicotine, whereas infusion of a selective α7 agonist decreases motivation.
“However, antagonizing α7 type nAChRs in the NAc or anterior cingulate cortex in the rat increases the motivation to self-administer nicotine, whereas infusion of a selective α7 agonist decreases motivation, as measured using a progressive ratio schedule (Brunzell and McIntosh 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brunzell and McIntosh 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationreasoningα7-type nAChRs may modulate rather than mediate nicotine reinforcement, so the effect of α7 knockout may be more subtle than knockout of β2* nAChRs.
“α7-type nAChRs may modulate, rather than mediate, nicotine reinforcement and therefore the effect of α7 knockout may be more subtle than knockout of β2 Ã nAChRs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationKnockout of the β2 subunit abolishes nicotine-mediated DA release, nicotine-induced locomotor activation, nicotine self-administration, and nicotine place preference.
“Knockout of the β2 subunit abolishes nicotine-mediated DA release (Picciotto et al. 1998;Grady et al. 2001), nicotine-induced locomotor activation (King et al. 2004), nicotine selfadministration (Picciotto et al. 1998;Maskos et al. 2005), and nicotine place preference (Walters et al. 2006;Brunzell et al. 2009;Mineur et al. 2009a).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationDependence on tobacco smoking depends on the balance between rewarding and aversive actions of nicotine and on escape from the aversive consequences of nicotine withdrawal.
“Dependence on tobacco smoking depends not only on the balance between the rewarding and aversive action of nicotine described above, but also on escape from the aversive consequences of nicotine withdrawal (Doherty et al. 1995;Kenny and Markou 2001).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationMost MHb neurons also produce and corelease glutamate, which is considered the major functional transmitter at the MHb-IPN synapse.
“However, it is believed that most MHb neurons also produce and corelease glutamate, with this excitatory neurotransmitter considered the major functional transmitter at the MHb-IPN synapse (Mata et al. 1977;Vincent et al. 1980;Girod et al. 2000;Ren et al., 2011).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe IPN receives massive cholinergic innervation from the MHb, with MHb cholinergic neurons coreleasing glutamate and providing the major source of glutamatergic input to the IPN.
“The IPN receives massive cholinergic innervation from MHb (Ren et al. 2011), with MHb cholinergic neurons coreleasing glutamate and providing the major source of glutamatergic input to the IPN (Ren et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ren et al. 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationnAChRs are expressed throughout the brain on excitatory and inhibitory neurons, with the ability to increase inhibition when excitation is high and increase excitation when circuits are less active.
“nAChRs are expressed throughout the brain on both excitatory and inhibitory neurons, with the ability to increase inhibition of circuits when excitation is high and to increase excitation when circuits are less active (Picciotto 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Picciotto 2003 source
May combine two claims.
PremisecitationNicotine can modulate behavioral function bidirectionally, acting as a stimulant and increasing anxiety under some conditions and decreasing activity and anxiety in others.
“The result of this circuit-level integration is that nicotine can modulate behavioral function bidirectionally, acting as a stimulant and increasing anxiety under some conditions and decreasing activity and anxiety in others (Picciotto 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Picciotto 2003 source
May combine two claims.
Interpretationnone givenNicotine reinforcement and avoidance of aversive withdrawal effects are fundamental for ongoing smoking, but other factors likely contribute to smoking behavior in humans.
“Nicotine reinforcement and avoidance of the aversive effects of nicotine withdrawal are clearly fundamental for ongoing smoking, but a number of other factors are also likely to contribute to smoking behavior in humans.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIncreasing acetylcholine signaling in the hippocampus via local knockdown of AChE results in increased avoidance of anxiogenic environments, increased immobility in response to inescapable stress, and decreased threshold for social defeat.
“Increasing acetylcholine signaling in the hippocampus via local knockdown of acetylcholine esterase (AChE) results in increased avoidance of anxiogenic environments, in-creased immobility in response to inescapable stress, and decreased threshold for social defeat (Mineur et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur et al. 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationSome individuals report smoking to improve attention, and smoking's ability to improve attentional function in individuals with schizophrenia likely contributes to their high rates of smoking.
“Some individuals report that they smoke to improve attention (Rusted and Warburton 1992;Warburton et al. 1992), and the ability of smoking to improve attentional function in individuals with schizophrenia (George et al. 2002) is likely to contribute to their extremely high rates of smoking.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationNicotine produces both anxiety-reducing and anxiety-increasing effects in rodents.
“Nicotine is known to have both anxiolytic and anxiogenic effects in rodents (File et al. 2000)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites File et al. 2000 source
May combine two claims.
PremisecitationMice administered nicotine during adolescence show deficits in the 5-choice serial reaction time task associated with decreased expression of mGluR2 receptors, rescued by mGluR2 agonists.
“Mice administered nicotine during the adolescent period show deficits in the 5-choice serial reaction time task that are associated with decreased expression of mGluR2 receptors, and that are rescued by administration of mGluR2 agonists (Counotte et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Counotte et al. 2011 source
May combine two claims.
PremisecitationOn average, smokers weigh approximately 5 kg less than nonsmokers and have significantly lower body mass index than nonsmokers.
“On average, smokers weigh ∼5 kg less than nonsmokers and have significantly lower body mass index than nonsmokers (Albanes et al. 1987).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Albanes et al. 1987 source
May combine two claims.
InterpretationreasoningOptimal nAChR stimulation is achieved at baseline in control subjects or wild-type mice with normal α7 nAChR levels, whereas nicotine from tobacco smoke can further improve attention in individuals with schizophrenia.
“These data suggest that optimal nAChR stimulation is achieved at baseline in control subjects or wild-type mice with normal α7 nAChR levels, whereas nicotine from tobacco smoke can further improve attention in individuals with schizophrenia.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationnAChRs in thalamo-cortico-thalamic loops are important for regulating glutamate release in this circuit and for mediating the effects of acetylcholine on attentional function.
“nAChRs in thalamo-cortico-thalamic loops are important for regulating glutamate release in this circuit, and for mediating the effects of acetylcholine on attentional function (Heath and Picciotto 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Heath and Picciotto 2009 source
Not checked in the free run.
May combine two claims.
Interpretationnone givennAChR subtypes containing α5, α3, and/or β4 nAChR subunits have been implicated in regulating the aversive properties of nicotine that control the quantities of the drug consumed and in the development of tobacco dependence.
“nAChR subtypes containing α5, α3, and/or β4 nAChR subunits have been implicated in regulating the aversive properties of nicotine that control the quantities of the drug consumed and in the development of tobacco dependence.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPrevious nicotine exposure increases the motivation of mice to work for food, and this is caused by non-β2 nAChRs.
“previous nicotine exposure increases the motivation of mice to work for food, and this is caused by non-β2 Ã nAChRs (Brunzell et al. 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brunzell et al. 2006 source
The paper relies on this without support.
Nicotine is the major reinforcing component of tobacco smoke.
“Nicotine, the major reinforcing component of tobacco smoke, acts in the brain through the neuronal nicotinic acetylcholine receptors (nAChRs).”
The paper relies on this without support.
The predominant nAChR subtypes in mammalian brain are those containing α4 and β2 subunits.
“The predominant nAChR subtypes in mammalian brain are those containing α4 and β2 subunits (denoted as α4β2 Ã nAChRs).”
The paper relies on this without support.
GLP-1 receptors are Gs-coupled G-protein-coupled receptors that enhance cAMP production.
“GLP-1 receptors are Gs-coupled G-proteincoupled receptors that enhance the production of cAMP.”
The paper relies on this without support.
In pancreatic β cells, GLP-1-stimulated increases in cAMP cause phosphorylation and nuclear translocation of β-catenin, which dimerizes with TCF7L2.
“In pancreatic β cells, GLP-1-stimulated increases in cAMP results in phosphorylation and nuclear translocation of β-catenin, which dimerizes with the transcription factor transcription factor 7-like 2 (TCF7L2).”
The paper relies on this without support.
α5, α3, and β4 nAChR subunits are densely expressed in the nucleus of the solitary tract in the hindbrain.
“In addition to the MHb-IPN pathway, α5, α3, and β4 nAChR subunits are densely expressed in the nucleus of the solitary tract (NTS) in the hindbrain.”
The paper relies on this without support.
β2 nAChRs in the prelimbic medial prefrontal cortex are important for normal performance of the 5-choice serial reaction time task measuring visual attention.
“Studies using knockout mice with lentiviralmediated reexpression have shown that β2 Ã nAChRs in the prelimbic medial prefrontal cortex (mPFC) are important for normal performance of the 5-choice serial reaction time task measuring visual attention.”
The paper relies on this without support.
nAChR subtypes regulate baseline activity of the basolateral amygdala (BLA).
“nAChR subtypes regulate baseline activity of the basolateral amygdala (BLA)”
The paper relies on this without support.
The anorexic effects of smoking have been well-documented in human subjects.
“The anorexic effects of smoking have been welldocumented in human subjects”
The paper relies on this without support.
β2α4α6 nAChRs are critical for nicotine reward and reinforcement.
“Whereas β2α4α6 Ã nAChRs are critical for nicotine reward and reinforcement”
The paper relies on this without support.
β4 nAChRs on POMC neurons can signal satiety.
“Although β4 Ã nAChRs on POMC neurons can signal satiety”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
α2-α10 does not contain twelve subunits
MinorThe inclusive range α2 through α10 contains nine subunits, not twelve. The endpoints are eight steps apart, so even counting both endpoints gives only nine.
Reported 12 · recomputed 8
“Twelve mammalian α subunits (α2-α10) and three β subunits (β2-β4) have been cloned.”
Cites
Journal of Biological Chemistry
Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,409 · see citing works
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229 · see citing works
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508 · see citing works
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070 · see citing works
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Self-citationAmos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310 · see citing works
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275 · see citing works
The habenula: from stress evasion to value-based decision-making
Hikosaka, O. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2866 · Cited by 955 · see citing works
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl438 · Cited by 850 · see citing works
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829 · see citing works
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · see citing works
Long-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720 · see citing works
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701 · see citing works
Jhou, T. C., Fields, H. L., Baxter, M. G., Saper, C. B., & Holland, P. C. (2009) · Neuron · doi:10.1016/j.neuron.2009.02.001 · Cited by 696 · see citing works
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686 · see citing works
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674 · see citing works
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663 · see citing works
Self-citationVariants in Nicotinic Receptors and Risk for Nicotine Dependence
Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., Saccone, N. L., Saccone, S. F., Bertelsen, S., Fox, L., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111711 · Cited by 648 · see citing works
Prefrontal Acetylcholine Release Controls Cue Detection on Multiple Timescales
Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.025 · Cited by 623 · see citing works
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594 · see citing works
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585 · see citing works
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 5× · see citing works
“Selective viral reexpression of β2 (Maskos et al. 2005; Pons et al. 2008) or α4 nAChRs in the VTA is sufficient to support both intra-VTA (Maskos et al.”
BackgroundInfluentialRepresentation of negative motivational value in the primate lateral habenula
Matsumoto, M., & Hikosaka, O. (2009) · Nature Neuroscience · doi:10.1038/nn.2233 · Cited by 547 · see citing works
Effect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483 · see citing works
Self-citationGöke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · see citing works
α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking
Berrettini, W., Yuan, X., Tozzi, F., Song, K., Francks, C., Chilcoat, H., Waterworth, D., Muglia, P., & Mooser, V (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002154 · Cited by 465 · see citing works
Nicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439 · see citing works
Self-citationYi, F., Brubaker, P. L., & Jin, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411487200 · Cited by 413 · see citing works
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407 · see citing works
Associations between smoking and body weight in the US population: analysis of NHANES II.
Albanes, D., Jones, D. Y., Micozzi, M. S., & Mattson, M. E. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.4.439 · Cited by 401 · see citing works
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · see citing works
Common cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382 · see citing works
Self-citationMineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219731110 · Cited by 375 · see citing works
Self-citationLynx1, a Cholinergic Brake, Limits Plasticity in Adult Visual Cortex
Morishita, H., Miwa, J. M., Heintz, N., & Hensch, T. K. (2010) · Science · doi:10.1126/science.1195320 · Cited by 365 · see citing works
Wooltorton, J. R. A., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03176.2003 · Cited by 363 · see citing works
Nicotinic receptor‐mediated effects on appetite and food intake
Jo, Y., Talmage, D. A., & Role, L. W. (2002) · Journal of Neurobiology · doi:10.1002/neu.10147 · Cited by 323 · see citing works
Liu, Z., & Habener, J. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706105200 · Cited by 323 · see citing works
Clarke, P. B., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22152-8 · Cited by 318 · see citing works
Ren, J., Qin, C., Hu, F., Tan, J., Qiu, L., Zhao, S., Feng, G., & Luo, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.038 · Cited by 315 · see citing works
Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312 · see citing works
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · see citing works
Self-citationSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · see citing works
Lecourtier, L., & Kelly, P. H. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.01.004 · Cited by 283 · see citing works
Frahm, S., Ślimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer, S., Filkin, S., Pons, S., Fontaine, J.-F., Tsetlin, V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.013 · Cited by 283 · see citing works
Avena, N. M., Bocarsly, M. E., Rada, P., Kim, A., & Hoebel, B. G. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.01.008 · Cited by 277 · see citing works
Lateral habenula neurons signal errors in the prediction of reward information
Bromberg-Martin, E. S., & Hikosaka, O. (2011) · Nature Neuroscience · doi:10.1038/nn.2902 · Cited by 275 · see citing works
Weiss, R. B., Baker, T. B., Cannon, D. S., von Niederhausern, A., Dunn, D. M., Matsunami, N., Singh, N. A., Baird, L., Coon, H., McMahon, W. M., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000125 · Cited by 271 · see citing works
Smoking withdrawal dynamics in unaided quitters.
Piasecki, T. M., Niaura, R., Shadel, W. G., Abrams, D., Goldstein, M., Fiore, M. C., & Baker, T. B. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.1.74 · Cited by 262 · see citing works
Nicotine as a modulator of behavior: beyond the inverted U
Picciotto, M. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00230-x · Cited by 257 · see citing works
Self-citationEffects of Smoking Abstinence on Visuospatial Working Memory Function in Schizophrenia
George, T. P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00296-2 · Cited by 226 · see citing works
Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5095-09.2010 · Cited by 226 · see citing works
Grady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222 · see citing works
Saccone, N. L., Saccone, S. F., Hinrichs, A. L., Stitzel, J. A., Duan, W., Pergadia, M. L., Agrawal, A., Breslau, N., Grucza, R. A., Hatsukami, D., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30828 · Cited by 215 · see citing works
Schilström, B., Svensson, H. M., Svensson, T. H., & Nomikos, G. G. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00114-6 · Cited by 207 · see citing works
Walters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206 · see citing works
Marchand, L. L., Derby, K. S., Murphy, S. E., Hecht, S. S., Hatsukami, D. K., Carmella, S. G., Tiirikainen, M., & Wang, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2271 · Cited by 202 · see citing works
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 201 · see citing works
GLP-1 acts on habenular avoidance circuits to control nicotine intake
Tuesta, L. M., Chen, Z., Duncan, A., Fowler, C. D., Ishikawa, M., Lee, B. R., Liu, X.-A., Lu, Q., Cameron, M., Hayes, M. R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4540 · Cited by 200 · see citing works
Self-citationUrges to smoke during the first month of abstinence: relationship to relapse and predictors
Doherty, K., Kinnunen, T., Militello, F. S., & Garvey, A. J. (1995) · Psychopharmacology · doi:10.1007/bf02246158 · Cited by 198 · see citing works
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197 · see citing works
Substance P containing and cholinergic projections from the habenula
Claudio Cuello, A., Emson, P. C., Paxinos, G., & Jessell, T. (1978) · Brain Research · doi:10.1016/0006-8993(78)90484-5 · Cited by 197 · see citing works
Nicotinic Receptor Gene Variants Influence Susceptibility to Heavy Smoking
Stevens, V. L., Bierut, L. J., Talbot, J. T., Wang, J. C., Sun, J., Hinrichs, A. L., Thun, M. J., Goate, A., & Calle, E. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0585 · Cited by 190 · see citing works
Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.2.238 · Cited by 189 · see citing works
Wang, J. C. C., Cruchaga, C., Saccone, N. L., Bertelsen, S. E., Liu, P., Budde, J., Duan, W., Fox, L. W., Grucza, R. A., Kern, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp231 · Cited by 187 · see citing works
Schlaepfer, I. R., Hoft, N. R., Collins, A. C., Corley, R. P., Hewitt, J. K., Hopfer, C. J., Lessem, J. M., McQueen, M. B., Rhee, S. H., & Ehringer, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.024 · Cited by 186 · see citing works
Smoking and schizophrenia: abnormal nicotinic receptor expression
Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00035-2 · Cited by 177 · see citing works
McGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165 · see citing works
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations
Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.1.14 · Cited by 159 · see citing works
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159 · see citing works
Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156 · see citing works
The genetics of sensory gating deficits in schizophrenia
Freedman, R., Olincy, A., Ross, R. G., Waldo, M. C., Stevens, K. E., Adler, L. E., & Leonard, S. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0032-2 · Cited by 153 · see citing works
A Risk Allele for Nicotine Dependence in CHRNA5 Is a Protective Allele for Cocaine Dependence
Grucza, R. A., Wang, J. C., Stitzel, J. A., Hinrichs, A. L., Saccone, S. F., Saccone, N. L., Bucholz, K. K., Cloninger, C. R., Neuman, R. J., Budde, J. P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.018 · Cited by 152 · see citing works
The Nicotinic Acetylcholine Receptor 5 Subunit Plays a Key Role in Attention Circuitry and Accuracy
Bailey, C. D. C., De Biasi, M., Fletcher, P. J., & Lambe, E. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-10.2010 · Cited by 146 · see citing works
Lips, E. H., Gaborieau, V., McKay, J. D., Chabrier, A., Hung, R. J., Boffetta, P., Hashibe, M., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., et al. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp288 · Cited by 145 · see citing works
Sherva, R., Wilhelmsen, K., Pomerleau, C. S., Chasse, S. A., Rice, J. P., Snedecor, S. M., Bierut, L. J., Neuman, R. J., & Pomerleau, O. F. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02279.x · Cited by 143 · see citing works
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137 · see citing works
Self-citationShih, P.-Y., Engle, S. E., Oh, G., Deshpande, P., Puskar, N. L., Lester, H. A., & Drenan, R. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0476-14.2014 · Cited by 136 · see citing works
Lambe, E. K., Olausson, P., Horst, N. K., Taylor, J. R., & Aghajanian, G. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-05.2005 · Cited by 135 · see citing works
Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence
Counotte, D. S., Goriounova, N. A., Li, K. W., Loos, M., van der Schors, R. C., Schetters, D., Schoffelmeer, A. N. M., Smit, A. B., Mansvelder, H. D., Pattij, T., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2770 · Cited by 132 · see citing works
Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129 · see citing works
Self-citationAltered Anxiety-Related Responses in Mutant Mice Lacking the β4 Subunit of the Nicotinic Receptor
Salas, R., Pieri, F., Fung, B., Dani, J. A., & De Biasi, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06255.2003 · Cited by 128 · see citing works
George, T. P., Sacco, K. A., Vessicchio, J. C., Weinberger, A. H., & Shytle, R. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b49e · Cited by 128 · see citing works
Feuerbach, D., Lingenhoehl, K., Olpe, H.-R., Vassout, A., Gentsch, C., Chaperon, F., Nozulak, J., Enz, A., Bilbe, G., McAllister, K. H., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.025 · Cited by 128 · see citing works
Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2056-10.2010 · Cited by 127 · see citing works
Parikh, V., Man, K., Decker, M. W., & Sarter, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5251-07.2008 · Cited by 127 · see citing works
Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors
Girod, R., Barazangi, N., McGehee, D., & Role, L. W. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00145-3 · Cited by 122 · see citing works
Caldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122 · see citing works
Self-citationHabenular TCF7L2 links nicotine addiction to diabetes
Duncan, A., Heyer, M. P., Ishikawa, M., Caligiuri, S. P. B., Liu, X.-A., Chen, Z., Micioni Di Bonaventura, M. V., Elayouby, K. S., Ables, J. L., Howe, W. M., et al. (2019) · Nature · doi:10.1038/s41586-019-1653-x · Cited by 119 · see citing works
Self-citationSaricicek, A., Esterlis, I., Maloney, K. H., Mineur, Y. S., Ruf, B. M., Muralidharan, A., Chen, J. I., Cosgrove, K. P., Kerestes, R., Ghose, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101546 · Cited by 118 · see citing works
Self-citationShao, W., Wang, D., Chiang, Y., Ip, W., Zhu, L., Xu, F., Columbus, J., Belsham, D. D., Irwin, D. M., Zhang, H., et al. (2012) · Diabetes · doi:10.2337/db12-0365 · Cited by 115 · see citing works
Brunzell, D. H., & McIntosh, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.299 · Cited by 114 · see citing works
Physostigmine induction of depressive symptomatology in normal human subjects
Risch, S. C., Cohen, R. M., Janowsky, D. S., Kalin, N. H., Sitaram, N., Christian Gillin, J., & Murphy, D. L. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90012-3 · Cited by 113 · see citing works
Wang, Y. Z., Broderick, P., Matakidou, A., Eisen, T. G., & Houlston, R. S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp287 · Cited by 112 · see citing works
Neurobiological mechanisms by which nicotine mediates different types of anxiety
File, S. E., Cheeta, S., & Kenny, P. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00889-4 · Cited by 110 · see citing works
Self-citationRada, P. V., Mark, G. P., Yeomans, J. J., & Hoebel, B. G. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00218-x · Cited by 106 · see citing works
Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS
Sugama, S., Cho, B. P., Baker, H., Joh, T. H., Lucero, J., & Conti, B. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03363-2 · Cited by 102 · see citing works
Andreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101 · see citing works
Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors
Kassam, S. M., Herman, P. M., Goodfellow, N. M., Alves, N. C., & Lambe, E. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2645-08.2008 · Cited by 100 · see citing works
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100 · see citing works
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100 · see citing works
Heath, C. J., & Picciotto, M. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.020 · Cited by 99 · see citing works
Self-citationInfluence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · see citing works
Caldarone, B. J., King, S. L., & Picciotto, M. R. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.023 · Cited by 95 · see citing works
Self-citationBrunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95 · see citing works
Nucleus Accumbens CREB Activity is Necessary for Nicotine Conditioned Place Preference
Brunzell, D. H., Mineur, Y. S., Neve, R. L., & Picciotto, M. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.11 · Cited by 92 · see citing works
Self-citationMineur, Y. S., Fote, G. M., Blakeman, S., Cahuzac, E. L. M., Newbold, S. A., & Picciotto, M. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.316 · Cited by 90 · see citing works
Self-citationSex differences in nicotine's effects on consummatory behavior and body weight in rats
Grunberg, N. E., Winders, S. E., & Popp, K. A. (1987) · Psychopharmacology · doi:10.1007/bf00217067 · Cited by 89 · see citing works
Mugnaini, M., Tessari, M., Tarter, G., Merlo Pich, E., Chiamulera, C., & Bunnemann, B. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02220.x · Cited by 88 · see citing works
Rollema, H., Guanowsky, V., Mineur, Y. S., Shrikhande, A., Coe, J. W., Seymour, P. A., & Picciotto, M. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.002 · Cited by 87 · see citing works
Self-citationSheffield, E. B., Quick, M. W., & Lester, R. A. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00138-6 · Cited by 87 · see citing works
Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study
Philip, N. S., Carpenter, L. L., Tyrka, A. R., Whiteley, L. B., & Price, L. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04441 · Cited by 86 · see citing works
Yang, K., Buhlman, L. M., Khan, G. M., Nichols, R. A., Jin, G.-Z., McIntosh, J. M., Whiteaker, P., Lukas, R. J., & Wu, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3003-10.2011 · Cited by 85 · see citing works
King, S. L., Marks, M. J., Grady, S. R., Caldarone, B. J., Koren, A. O., Mukhin, A. G., Collins, A. C., & Picciotto, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03837.2003 · Cited by 82 · see citing works
Self-citationThe role of acetylcholine in negative encoding bias: Too much of a good thing?
Mineur, Y. S., & Picciotto, M. R. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14641 · Cited by 78 · see citing works
Self-citationProgesterone modulation of α5 nAChR subunits influences anxiety‐related behavior during estrus cycle
Gangitano, D., Salas, R., Teng, Y., Perez, E., & De Biasi, M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00476.x · Cited by 76 · see citing works
Cytisine-based nicotinic partial agonists as novel antidepressant compounds
Mineur, Y. S., Eibl, C., Young, G., Kochevar, C., Papke, R. L., Gündisch, D., & Picciotto, M. R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149609 · Cited by 75 · cited 2× · see citing works
“…at endogenous nAChRs when cholinergic tone is high but increase activity of nAChRs when cholinergic tone is low, are effective in mouse models of antidepressant efficacy (Mineur et al. 2007, 2009b, 2011a; Rollema et al. 2009; Caldarone et al. 2011) and in human smokers (Philip et al. 2009).”
BackgroundSelf-citationTransmitters contained in the efferents of the habenula
Vincent, S. R., Staines, W. A., McGeer, E. G., & Fibiger, H. C. (1980) · Brain Research · doi:10.1016/0006-8993(80)90084-0 · Cited by 74 · see citing works
Warburton, D. M., Rusted, J. M., & Fowler, J. (1992) · Psychopharmacology · doi:10.1007/bf02247418 · Cited by 72 · see citing works
Brunzell, D. H., Chang, J. R., Schneider, B., Olausson, P., Taylor, J. R., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0099-z · Cited by 71 · see citing works
Self-citationMineur, Y. S., Mose, T. N., Blakeman, S., & Picciotto, M. R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13769 · Cited by 71 · see citing works
Self-citationMineur, Y. S., Cahuzac, E. L. M., Mose, T. N., Bentham, M. P., Plantenga, M. E., Thompson, D. C., & Picciotto, M. R. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0024-x · Cited by 71 · see citing works
Self-citationDepressive Characteristics of FSL Rats
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70 · see citing works
King, S. L., Caldarone, B. J., & Picciotto, M. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.024 · Cited by 70 · see citing works
Self-citationRusted, J. M., & Warburton, D. M. (1992) · Psychopharmacology · doi:10.1007/bf02247420 · Cited by 68 · see citing works
Voorhees, C. C., Schreiber, G. B., Schumann, B. C., Biro, F., & Crawford, P. B. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1026 · Cited by 66 · see citing works
Eckenrode, T. C., Barr, G. A., Battisti, W. P., & Murray, M. (1987) · Brain Research · doi:10.1016/0006-8993(87)90095-3 · Cited by 64 · see citing works
Hannestad, J. O., Cosgrove, K. P., DellaGioia, N. F., Perkins, E., Bois, F., Bhagwagar, Z., Seibyl, J. P., McClure-Begley, T. D., Picciotto, M. R., & Esterlis, I. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.004 · Cited by 63 · see citing works
Self-citationHeath, C. J., King, S. L., Gotti, C., Marks, M. J., & Picciotto, M. R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.130 · Cited by 59 · see citing works
Self-citationThe role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 56 · see citing works
Cigarette smoking: Effects upon self-rated stress and arousal over the day
Parrott, A. C. (1993) · Addictive Behaviors · doi:10.1016/0306-4603(93)90055-e · Cited by 53 · see citing works
Mineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49 · see citing works
Self-citationCholinergic Modulation of Appetite-Related Synapses in Mouse Lateral Hypothalamic Slice
Jo, Y., Wiedl, D., & Role, L. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3638-05.2005 · Cited by 48 · see citing works
Place preference conditioning with ventral tegmental injections of cytisine
Museo, E., & Wise, R. A. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00656-3 · Cited by 48 · see citing works
Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47 · see citing works
Self-citationChronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry
Arvin, M. C., Jin, X.-T., Yan, Y., Wang, Y., Ramsey, M. D., Kim, V. J., Beckley, N. A., Henry, B. A., & Drenan, R. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2816-18.2019 · Cited by 42 · see citing works
Calarco, C. A., & Picciotto, M. R. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz010 · Cited by 40 · see citing works
Self-citationEffects of feeding and insulin on extracellular acetylcholine in the amygdala of freely moving rats
Hajnal, A., Pothos, E. N., Lénárd, L., & Hoebel, B. G. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01291-2 · Cited by 39 · see citing works
Mineur, Y. S., Brunzell, D. H., Grady, S. R., Lindstrom, J. M., McIntosh, J. M., Marks, M. J., King, S. L., & Picciotto, M. R. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00468.x · Cited by 33 · see citing works
Self-citationMineur, Y. S., Einstein, E. B., Bentham, M. P., Wigestrand, M. B., Blakeman, S., Newbold, S. A., & Picciotto, M. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.269 · Cited by 33 · see citing works
Self-citationMata, M. M., Schrier, B. K., & Moore, R. Y. (1977) · Experimental Neurology · doi:10.1016/0014-4886(77)90116-9 · Cited by 33 · see citing works
Association of TCF7L2 Allelic Variations with Gastric Function, Satiation, and GLP‐1 Levels
Vázquez‐Roque, M. I., Camilleri, M., Vella, A. V., Carlson, P., Laugen, J. M., & Zinsmeister, A. R. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00284.x · Cited by 24 · see citing works
Brown, K. L., Comalli, D. M., Biasi, M. D., & Woodruff-Pak, D. S. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00166 · Cited by 24 · see citing works
Calarco, C. A., Li, Z., Taylor, S. R., Lee, S., Zhou, W., Friedman, J. M., Mineur, Y. S., Gotti, C., & Picciotto, M. R. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13966 · Cited by 24 · see citing works
Self-citationM1352 Association of Tcf7l2 Genotype, Gastric Function and Satiation
Vázquez‐Roque, M. I., Camilleri, M., Vella, A. V., et al. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)61776-3
Flagged first, then by citations
2 of the 147 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy
Wang, S., Wang, R., Hu, D., Zhang, C.-X., Cao, P., & Huang, J. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00538-5 · Cited by 76 · see citing works
An inhibitory brainstem input to dopamine neurons encodes nicotine aversion
Liu, C. J., Tose, A. J., Verharen, J. P. H., Zhu, Y., Tang, L. W., de Jong, J. W., Du, J. X., Beier, K. T., & Lammel, S. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.003 · Cited by 55 · see citing works
Zhu, P., Jin, Z., Kang, G., Jia, Y., Liu, D., Zhang, Q., Guo, F., Jia, Y., Jiao, Y., Li, J., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00934-z · Cited by 46 · see citing works
“Nicotinic acetylcholine receptors (nAChRs) are ligandgated ion channel proteins comprising pentameric subunits using various combinations of alpha (α1-α10) or non-α (β1–β4, γ, δ, or ε) type openings and are regulated by the binding of acetylcholine or nicotine agonists, such as nicotine [11].”
BackgroundClark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S. A., Ahmadzadeh, S., McGregor, D., Girma, B., Shekoohi, S., & Kaye, A. D. (2023) · Health Psychology Research · doi:10.52965/001c.81043 · Cited by 45 · see citing works
Nunes, E. J., Addy, N., Conn, P. J., & Foster, D. J. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-023858 · Cited by 28 · see citing works
Jiao, Y., Kang, G., Pan, P., Fan, H., Li, Q., Li, X., Li, J., Wang, Y., Jia, Y., Zhang, L., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04742-7 · Cited by 26 · see citing works
“In non-neuronal tissues, such as lung, colon, pancreas, skin, gall bladder, and small/large intestine tissues, ACh and cholinergic proteins have been detected [8].”
BackgroundWang, M., Bai, Q.-X., Zheng, X.-X., Hu, W., Wang, S., Tang, H., Yu, A., Yang, B., & Kuang, H. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116992 · Cited by 23 · see citing works
Sweileh, W. M. (2024) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-024-00595-w · Cited by 21 · see citing works
Advancements in Cardiovascular Disease Research Affected by Smoking
Fu, M.-X., Mei, A.-H., Min, X.-W., Yang, H.-D., Wu, W.-W., Zhong, J.-X., Li, C., & Chen, J. (2024) · Reviews in cardiovascular medicine · doi:10.31083/j.rcm2508298 · Cited by 23 · see citing works
Frinculescu, A., Coombes, G., Shine, T., et al. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3277 · Cited by 19 · see citing works
Rare coding variants in CHRNB2 reduce the likelihood of smoking
Rajagopal, V. M., Watanabe, K., Mbatchou, J. S., Ayer, A. H., Quon, P., Sharma, D., Kessler, M. D., Praveen, K., Gelfman, S., Parikshak, N., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01417-8 · Cited by 15 · see citing works
Electronic nicotine delivery systems (ENDS): A convenient means of smoking?
Sala, M., & Gotti, C. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106885 · Cited by 19 · see citing works
Nicotine pouches: a narrative review of the existing literature
Al-Otaibi, H. M., & Althobiani, M. A. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1641308 · Cited by 26 · see citing works
“Over a decade ago, the harm reduction continuum was proposed (32, 57).”
InfluentialFamily functioning and nicotine dependence among smoking fathers: a cross-sectional study
Guo, Y., Liu, D., Wang, Y., Huang, M., Jiang, N., Hou, Q., Feng, B., Wu, W., Wu, Y., Qi, F., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-15475-4 · Cited by 16 · see citing works
“In addition, as the duration of smoking increases, nicotine in tobacco is involved in strengthening brain circuits with the help of high-affinity isoforms of α4 and β2 subunits (α4β2 * nAChRs), promoting psychological and physiological dependence on tobacco [27].”
BackgroundNicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity
Lupacchini, L., Maggi, F., Tomino, C., Dominicis, C. D., Mollinari, C., Fini, M., Bonassi, S., Merlo, D., & Russo, P. (2020) · Molecules · doi:10.3390/molecules26010101 · Cited by 17 · see citing works
Ding, R., Ren, X., Sun, Q., Sun, Z., & Duan, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.08.012 · Cited by 17 · see citing works
Li, H., Su, W., Cai, J., Zhao, L., & Li, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1126777 · Cited by 19 · see citing works
“nAChRs have a large number of subunits, of which α4β2 nAChRs mediate many behaviors related to nicotine addiction (Picciotto and Kenny, 2021).”
BackgroundKang, N., Qiu, W., Wang, B., Tang, D., & Shen, X. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23404 · Cited by 13 · see citing works
“In the KEGG pathway analysis, the mechanism of nicotine addiction has been confirmed to be one of the main factors of lung cancer.(46) With regard to peroxisome proliferator‐activated receptors F IGURE 5 Immunofluorescence assay showed that the knockdown of HBA and HBB promoted the proliferation of H1299 cells.”
MethodMicroglia sustain anterior cingulate cortex neuronal hyperactivity in nicotine-induced pain
Long, D.-D., Zhang, Y.-Z., Liu, A., Shen, L., Wei, H.-R., Lou, Q., Hu, S., Chen, D., Chai, X., & Wang, D. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02767-0 · Cited by 14 · see citing works
“In addition to the release of VTA dopamine indirectly via stimulation of nAChRs, nicotine dependence may be related to neuronal interactions, transmitter release, receptor sensitization and desensitization [48, 49].”
BackgroundPrevalence of nicotine dependence among smokers aged 40 years and older in China
Ji, Y., Cong, S., Fan, J., Wang, N., Wang, W., Song, X., & Fang, L. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2024.05.003 · Cited by 14 · see citing works
Fan, L., Chen, H., Liu, Y. U., Hou, H., & Hu, Q. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173510 · Cited by 13 · see citing works
Gao, X., Zhang, M.-Z., Yang, Z.-G., Niu, X.-Y., Zhou, B.-Q., Chen, J.-L., Wang, W.-J., Wei, Y.-R., Han, S.-Q., Cheng, J.-L., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13516 · Cited by 12 · see citing works
Zur Komorbidität von Posttraumatischer Belastungsstörung und Sucht in biopsychosozialer Perspektive
Kapfhammer, H. (2021) · Neuropsychiatrie · doi:10.1007/s40211-020-00384-4 · Cited by 12 · see citing works
New medications development for smoking cessation
Lengel, D., & Kenny, P. J. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100103 · Cited by 12 · see citing works
Self-citationTang, Y., Bryant, M., Li, M., Min, S., Pellar, G., Wu, Q., Yang, D.-J., Kang, H.-K., Sepehr, E., He, X., et al. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae120 · Cited by 11 · see citing works
A novel effect of PDLIM5 in α7 nicotinic acetylcholine receptor upregulation and surface expression
Li, Z.-L., Gou, C., Wang, W., Li, Y., Cui, Y., Duan, J.-J., & Chen, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04115-y · Cited by 10 · see citing works
Boiangiu, R. Ş., Brinza, I., Honceriu, I., Mihăşan, M., & Hriţcu, L. (2023) · Biomolecules · doi:10.3390/biom14010023 · Cited by 10 · see citing works
“NIC is highly addictive and can lead to dependence, making it challenging for individuals to quit smoking or using nicotine-containing products [1,2].”
BackgroundExploring the association between melatonin and nicotine dependence (Review)
GEORGAKOPOULOU, V. E., Sklapani, P., Τράκας, Ν., Reiter, R. J., & Spandidos, D. A. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5406 · Cited by 12 · see citing works
Anesthesiologists and the Other Pandemic: Tobacco Use
Warner, D. O. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004346 · Cited by 9 · see citing works
Salivary oxidative stress level among tobacco chewers and smokers: A comparative Study
Balasubramaniam, A., & Arumugham, M. I. (2022) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_116_22 · Cited by 9 · see citing works
Miyoshi, K., Kimura, Y., Nakahata, M., & Miyawaki, T. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/175623 · Cited by 9 · see citing works
“However, tobacco leaves contain nicotine: one of the alkaloids that combine at nicotinic acetylcholine receptors (nAChRs) 3 and induce secretion of dopamine, a neurotransmitter in the brain that induces pleasure, thus causing addiction 4 .”
BackgroundNeurobiology of Stress-Induced Nicotine Relapse
Wang, X., Chen, Y., Dong, J., Ge, J., Liu, X., & Liu, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031482 · Cited by 10 · see citing works
“The direct evidence that nAChRs are involved in the rewarding effects of nicotine is from studies using animal brain slices and behavioral testings [66].”
BackgroundSoto‐Montenegro, M. L., García‐Vázquez, V., Lamanna‐Rama, N., Montoya, G. L., Desco, M., & Ambrosio, E. (2022) · Scientific Reports · doi:10.1038/s41598-022-08698-9 · Cited by 9 · see citing works
“(2) Differences in brain glucose metabolism between LEW-Sal animals and F344-Sal animals.”
BackgroundThe role of nicotinic receptors in alcohol consumption
Kamens, H. M., Flarend, G., & Horton, W. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106705 · Cited by 8 · see citing works
Kim, B., & Im, H. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00227-0 · Cited by 9 · see citing works
“…in the mesolimbic reward pathway (i.e. ventral tegmental area to nucleus accumbens) and habenulo-interpeduncular pathway, nicotine is thought to exert its reinforcing and aversive effects, respectively, that ultimately contribute to nicotine addiction and continued cigarette smoking [4, 5].”
BackgroundSanchez, M. E., Zhu, M., Magee, S., et al. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100082 · Cited by 9 · see citing works
The Scientific Basis for the Regulation of Flavors in Tobacco Products
Bold, K. W., Kong, G., & O’Malley, S. S. (2024) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-080921-075624 · Cited by 8 · see citing works
Harrell, P. T., Brandon, T. H., Stark, S. E., Simmons, V. N., Barnett, T. E., Quinn, G. P., & Chun, S. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109861 · Cited by 8 · see citing works
Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers
de Boer, A. H., Hagedoorn, P., & Grasmeijer, F. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2112568 · Cited by 8 · see citing works
Shen, Y., Huang, Q., Ji, M., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10161-x · Cited by 8 · see citing works
“Furthermore, tobacco smoking leads to exposure to carcinogens such as nicotine-derived nitrosamine ketone (NNK) and nicotine, which exert their biological functions by binding to nAChRs [26].”
BackgroundNicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV2 Infection SeverityPreprint
Lupacchini, L., Maggi, F., Tomino, C., et al. (2020) · Preprints.org · doi:10.20944/preprints202012.0467.v1 · Cited by 8 · see citing works
Gotti, C., Clementi, F., & Zoli, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107067 · Cited by 7 · see citing works
Alshutairi, A. M., Alzahrani, A. H., & Almontshry, A. M. (2024) · BMC Public Health · doi:10.1186/s12889-024-18398-w · Cited by 7 · see citing works
“Cigarette smoking is harmful to one’s health since it has been linked to the genesis of many ailments, including lung cancer, cardiovascular disease, stroke, and asthma, among others [1].”
BackgroundConway, K. P., Michel, E., Eig, S., He, J.-P., & Merikangas, K. R. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230988 · Cited by 8 · see citing works
Zhang, M., Zhao, Y., & Shi, H. (2023) · Plant Direct · doi:10.1002/pld3.478 · Cited by 8 · see citing works
Tan, X., Neslund, E. M., & Ding, Z. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109495 · Cited by 6 · see citing works
Pharmacological strategies for appetite modulation in eating disorders: a narrative review
Popov, M. Y., Витальевна, Л. О., Козловский, В. Л., & Popov, Y. V. (2023) · Consortium Psychiatricum · doi:10.17816/cp6150 · Cited by 6 · see citing works
Kunset, P., Punsawad, C., Petsirasan, R., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20176703 · Cited by 6 · see citing works
Understanding nicotine addiction and the health effects of nicotine use
Pöğün, Ş., & Arman, A. R. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10002020 · Cited by 6 · see citing works
Aquino, J. P. D., MacLean, R. R., Gueorguieva, R. V., DeVito, E. E., Eid, T., & Sofuoglu, M. (2022) · Addiction Biology · doi:10.1111/adb.13161 · Cited by 6 · see citing works
“Such discrepancy may be explained by the diverse mechanisms underlying the various effects of nicotine.(19) Notably, the nicotinic acetylcholine receptor (nAChR) subtypes that mediate the reinforcing, withdrawal-suppressing, cognitive enhancing and physiological effects of nicotine show significant variation in their…”
BackgroundShankar, K., Bonnet-Zahedi, S., & George, O. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06852-5 · Cited by 6 · see citing works
Nicotinic acetylcholine receptors-targeting drug discovery
Zhang, D., Zheng, H., Cui, K., Li, Y., Liu, C., Mao, J., Zheng, J., & Wan, Y. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118679 · Cited by 5 · see citing works
Rivera-García, L. G., Francis-Malavé, A. M., Castillo, Z. W., Uong, C. D., Wilson, T. D., Ferchmin, P. A., Eterović, V. A., Burton, M. D., & Carrasquillo, Y. (2024) · Journal of Inflammation · doi:10.1186/s12950-023-00373-8 · Cited by 6 · see citing works
“This is particularly important given that 4R has been shown to bind to and modulate α4β2 nAChRs [15, 28], which have been previously linked to nicotine addiction [70, 71].”
BackgroundTian, Z. R., Sharma, A., Muresanu, D. F., Sharma, S., Feng, L., Zhang, Z., Li, C., Buzoianu, A. D., Lafuente, J. V., Nozari, A., et al. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.07.002 · Cited by 5 · see citing works
Shen, Y., Huang, Q., Yuan, X., Gong, H., Xu, C., Du, H.-D., Hsueh, C., & Zhou, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02051-x · Cited by 6 · see citing works
“Tobacco smoking results in nicotine exposure, which exerts its effects by binding to nAChRs [15] (Fig.”
Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression
Cai, J., Wang, J., Wang, Z., Wang, J., Jia, Y., & Ma, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1489958 · Cited by 5 · see citing works
“…leading to channel opening and altered ion fluxes in the cell. nAChRs consist of α1 ∼ α10 subunits, four β1 ∼ β4 subunits, δ, ε and γ subunits, arranged in the form of heteromeric or homomeric structures, thereby underpinning their multifaceted roles (Picciotto and Kenny, 2021; Papke, 2014).”
Lung cancer in non-smoking women (LCINSW): from risk factors to precision therapy
Zhao, J., Li, M., Niu, L., Zhao, Y., & Song, X. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10289-9 · Cited by 5 · see citing works
“1), which promote nicotine addiction and amplify susceptibility to tobacco carcinogens [57].”
Barakat, M. M., Alzaghari, L. F., Al‐Najjar, M. A. A., Al‐Zuhd, T., Abdaljaleel, M., Abu-Qatouseh, L., Thiab, S. H., & Alqudah, A. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-26799-z · Cited by 4 · see citing works
“…rewarding and addictive potential of nicotine, creating a cycle that reinforces dependency and exacerbates hormonal dysregulation in exposed animals 42 . nicotine, cotinine, adrenaline, and beta-endorphin levels were significantly reduced by CDP-choline for 3 weeks, especially in the 1-hour…”
Implementing Core Genes and an Omnigenic Model for Behaviour Traits Prediction in Genomics
Rančelis, T., Domarkienė, I., Ambrozaitytė, L., & Utkus, A. (2023) · Genes · doi:10.3390/genes14081630 · Cited by 4 · see citing works
Huo, Y.-X., Wang, X.-J., Hu, W., & Yue, C. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/189394 · Cited by 4 · see citing works
“In this process, nicotine can interact with nicotinic acetylcholine receptors (nAChRs) in the fetal lung, leading to change in the structure and function of the lung of the offspring 2,20,21 .”
BackgroundFraile‐Μartinez, O., Montero, C. G., Ortega, M. A., Varaona, A., Gutiérrez-Rojas, L., Álvarez‐Mon, M., & Álvarez-Mon, M. Á. (2025) · Healthcare · doi:10.3390/healthcare13151783 · Cited by 3 · see citing works
“These receptors are densely expressed in the brain’s reward circuitry, where nicotine’s actions contribute to the development and persistence of tobacco dependence and addiction [2].”
Jiang, Y., Li, H., Li, Z., Du, S., Zhang, R., Zhao, Y., Christiani, D. C., Shen, S., & Chen, F. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-4 · Cited by 3 · see citing works
Nicotinic acetylcholine receptors in the brain
Barrantes, F. J. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00004-4 · Cited by 3 · see citing works
Raghunathan, R., Gutiérrez, J., Liu, C., et al. (2023) · Journal of Biomedical Optics · doi:10.1117/1.jbo.28.7.076002 · Cited by 3 · see citing works
The effect of CNQX on self-administration: present in nicotine, absent in methamphetamine model
Hrickova, M., Amchová, P., & Kučerová, J. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1305412 · Cited by 3 · see citing works
Hajiasgharzadeh, K., Shahabi, P., Karimi‐Sales, E., & Alipour, M. R. (2024) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2024.136227 · Cited by 3 · see citing works
Lv, Q., Bu, C., Xu, H., Liang, X., Ma, L., Wang, W., Ma, Z., Cheng, M., Tan, S., Zheng, N., et al. (2024) · Brain and Cognition · doi:10.1016/j.bandc.2024.106223 · Cited by 3 · see citing works
Generative artificial intelligence-enabled dynamic detection of rat nicotine-related circuits
Gong, C., Jing, C., Liu, X., Wang, V. X., Tang, C. Y., Kenny, P. J., Li, Y., Chen, Z., & Wang, S. (2023) · Neural Computing and Applications · doi:10.1007/s00521-023-09307-0 · Cited by 3 · see citing works
Self-citationRare coding variants in CHRNB2 reduce the likelihood of smokingPreprint
Rajagopal, V. M., Watanabe, K., Mbatchou, J. S., Ayer, A. H., Quon, P., Sharma, D., Kessler, M. D., Praveen, K., Gelfman, S., Parikshak, N., et al. (2022) · medRxiv · doi:10.1101/2022.10.27.22281470 · Cited by 3 · see citing works
Yahya, L., Mandoura, N. A., & Harere, R. (2024) · Cureus · doi:10.7759/cureus.61038 · Cited by 2 · see citing works
Chellian, R., Behnood‐Rod, A., & Bruijnzeel, A. W. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112531 · Cited by 2 · see citing works
The α5-nAChR/GINS4 axis contributed to nicotine-promoted lung adenocarcinoma progression
Wang, Z., Cai, J., Yang, M., et al. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115828 · Cited by 2 · see citing works
Understanding varenicline function via key receptor and ligand interactions
Aiken, S., Fiorito, D., Harper, M., Pikus, G., Underhill, J., Murray, J., Rawlinson, J., O’Donoghue, A. C., Gotti, C., Lummis, S. C. R., et al. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102992 · Cited by 3 · see citing works
Xu, S., Tian, Y., Chen, X., Zhang, W., Mei, Y., Zhang, Q., & Zhang, H. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100084 · Cited by 2 · see citing works
Nicotine Differentially Modulates Emotional-Locomotor Interactions for Adult or Adolescent Rats
Novoa, C., Solano, J. L., Ballesteros-Acosta, H., Lamprea, M. R., & Ortega, L. A. (2022) · Revista Colombiana de Psicología · doi:10.15446/rcp.v31n1.89822 · Cited by 2 · see citing works
“…addition to locomotor stimulating effects of nicotine, other studies have evaluated emotional effects induced by nicotine with paradigms frequently employed to assess anxiety-like responses in animal models (Bishnoi et al., 2020; Counotte et al., 2011; Morud et al., 2018; Picciotto & Kenny, 2020).”
BackgroundGut clues to weight gain after quitting smoking
Spindler, M. P., Faith, J. J., Wang, J., & Kenny, P. J. (2021) · Nature · doi:10.1038/d41586-021-03548-6 · Cited by 2 · see citing works
Self-citationThompson, B. M., Tracy, M. E., Huynh, Y. W., Dwoskin, L. P., Barrett, S. T., & Bevins, R. A. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000707 · Cited by 1 · see citing works
Enantiospecific Positive Allosteric Modulation of α4β2 Nicotinic Receptor Subtypes
Gaona, J., Gadekar, P. K., Abdelwahed, K. S., Sanchez, N. E., Rolling, A., Beaudoin, R., Bill, B., Kerr, A. T., Thakur, G. A., & Hamouda, A. K. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00115 · Cited by 1 · see citing works
Jing, C., An, X., & Fang, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1553200 · Cited by 1 · see citing works
Maimaiti, A., Pan, L., Liu, Y., Huang, M., Ding, W., Yang, W., Sun, K., Wang, Y., & Wang, Z. (2025) · Cerebrovascular Diseases · doi:10.1159/000546508 · Cited by 1 · see citing works
Liu, Y., Huang, L., Wang, R., Qi, F., Liu, Y., Chen, Q., Mialon, M., Chen, L., Pinan‐Lucarré, B., & Gao, S. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003423 · Cited by 1 · see citing works
Yeap, Z. J. S., Argote, M., Nadler, E. B., He, P., Parvaz, M. A., & Rabin, R. A. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106480 · Cited by 1 · see citing works
Prospective associations between nicotine type and the continuation of youth e-cigarette use
Harrington, T. R., Ferketich, A. K., Lü, B., Wagner, D. D., & Roberts, M. E. (2025) · BMC Public Health · doi:10.1186/s12889-025-25481-3 · Cited by 1 · see citing works
“The vast majority of e-cigarettes contain nicotine, a highly addictive chemical [9, 10].”
Pathology of oral nicotine pouches and their addiction mechanisms
Zou, H., Lyu, Q., & Hu, S. (2025) · Journal of Dentistry · doi:10.1016/j.jdent.2025.106272 · Cited by 4 · see citing works
Alshehri, F. S. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13854-8 · Cited by 2 · see citing works
“Nicotine dependence is characterized as a chronic and relapsing condition that cause addictive behavior to nicotine, that involve the brain’s dopaminergic reward pathways, reinforcement and withdrawal upon cessation [57, 58].”
Li, H. T., Zhang, Y., Wang, Q., Li, L., Zheng, G., Zheng, R., Wang, T., Yang, X., Shi, Z., Yang, F., et al. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.140799 · Cited by 1 · see citing works
Anatabine: a substitute for the medicinal activity of nicotine
Guo, X., Li, Y., Liu, C., Fu, Y., & Gao, N. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178537 · Cited by 1 · see citing works
Disruption of chrna5 blunts aversion and adaptive transcriptomic responses to nicotine and alcohol
Goel, T., Raine, J., Kibat, C., Collado, J. W., Banerjee, T. D., & Mathuru, A. S. (2026) · iScience · doi:10.1016/j.isci.2026.114735 · Cited by 1 · see citing works
Oxytocin as a neurotherapeutic target for nicotine withdrawal and craving modulation
Thanekar, R., Taksande, B. G., Umekar, M., & Vinchurney, M. D. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102595 · Cited by 1 · see citing works
Rare coding variants in CHRNB3 associate with reduced daily cigarette smoking across ancestries
Rajagopal, V. M., Ziyatdinov, A., Joseph, T., Ayer, A. H., Ahmed, M., Mbatchou, J. S., Zou, Y., Averitt, A., Banerjee, N., Cantor, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68825-2 · Cited by 1 · see citing works
“Unlike the β 2 subunit, which has been extensively studied using gene manipulation in animal models for many decades, the β 3 subunit is relatively poorly studied 26 .”
Nikotinski acetilholinski receptor kot farmakološka tarča pri pljučnem raku
Kononenko, V., Bele, T., Novak, S., et al. (2022) · Acta Biologica Slovenica · doi:10.14720/abs.65.1.15941 · Cited by 1 · see citing works
Janowska, K., Szydziak, J., Hrapkowicz, A., Dąbkowska, D., Szeidl, O., Rehan, D., & Mioskowska, A. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.77.56630 · Cited by 1 · see citing works
Inpatient Smoking Cessation – A Quality Improvement Project
Harris, S. (2021) · Journal of Hospital and Healthcare Administration · doi:10.29011/2688-6472.000150 · Cited by 1 · see citing works
D’Souza, M. S., Seeley, S. L., Emerson, N., Rose-Malkamaki, M. J., Ho, S.-P., Tsai, Y., Kuo, H. R., Huan, C. Y., & Rorabaugh, B. R. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173338 · Cited by 1 · see citing works
Tan, Q., Li, S., Yu, M., Zhao, J., Chi, X., Han, Y., & Guo, Z. (2023) · Brain and Behavior · doi:10.1002/brb3.3059 · Cited by 1 · see citing works
Alshutairi, A. M., Alzahrani, A. H., & Almontshry, A. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3173210/v1 · Cited by 1 · see citing works
Insights into the Brain Effects of a Bacterial Nicotine Derivative – 6-Hydroxy-L-NicotinePreprint
Boiangiu, R. Ş., Brinza, I., Honceriu, I., Mihăşan, M., & Hriţcu, L. (2023) · Preprints.org · doi:10.20944/preprints202310.0340.v1 · Cited by 1 · see citing works
Soto‐Montenegro, M. L., García, V., Lamanna‐Rama, N., Montoya, G. L., Desco, M., & Ambrosio, E. (2021) · Research Square · doi:10.21203/rs.3.rs-472435/v1
Li, Z., Gou, C., Wang, W., Li, Y., Cui, Y., Duan, J., & Chen, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-860148/v1
Twin studies of smoking and tobacco use
Kaprio, J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821514-2.00022-2
- Authors
- Picciotto, M. R., & Kenny, P. J.
- Affiliations
- Yale University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2020-04-27
- Volume
- 11
- Issue
- 5
- Pages
- a039610
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC8091956
- OpenAlex
- W3017576137
- Cited by
- 157
- References
- 147
- Citations by year
- 2026: 30 · 2025: 31 · 2024: 29 · 2023: 29 · 2022: 23 · 2021: 6 · 2020: 1
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotine dependence, smoking, nicotinic acetylcholine receptors, alpha4beta2 nAChR, nAChR subunits, lung cancer, nicotine reinforcement, appetite
- MeSH terms
- Humans, Tobacco Use Disorder, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review